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Dáil debate on cannabis
See pages 6–9.
National Drugs Strategy 
Conference 
On 16 January 2014 the Department of Health hosted a half-day conference for those in the 
government, statutory, community and voluntary sectors working in the drugs and alcohol 
field. Tánaiste Eamon Gilmore TD (pictured) and Minister of State Alex White TD addressed 
the conference. They were followed by Fergus McCabe of CityWide Drugs Crisis Campaign 
and Tony Duffin of Ana Liffey Drug Project (ALDP), representing the community and voluntary 
sectors. 
Reaffirming the primacy of the National Drugs Strategy and the five ‘pillars’, Tánaiste Gilmore 
stressed the importance of maintaining the partnership approach in face of emerging 
challenges, including prescription drugs and grow houses. Minister White outlined the 
extensive review of the drugs task forces and the series of bilateral meetings with other 
government ministers, state agencies and the community and voluntary sectors on drugs 
and alcohol issues, which had just concluded. Susan Scally of the Drug Policy Unit in the 
Department of Health described the outcomes of the review and the bilaterals and this 
information is covered in the article ‘Supporting local efforts to tackle the drug problem’ on  
p.4 of this issue. 
Speaking on behalf of the community sector and reflecting on the last twenty or so years of 
drug policy implementation in Ireland, Fergus McCabe listed five things necessary to ensure 
effective policy implementation:
 ■ political commitment with a special focus on disadvantage, 
 ■ effective cross-cutting and co-ordinating structures, 
 ■ equitable distribution of adequate resources, 
 ■ timely and relevant research and evaluation, and 
 ■ processes for real engagement involving all sectors.
Continued on p. 3
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2Health Research Board welcomes  
new CEO
Dr Graham Love took over as chief executive 
of the Health Research Board (HRB) at the 
end of March. He replaces Enda Connolly, 
who retired on 31 January 2014 after more 
than five years in the position. 
Graham will bring 15 years’ leadership and 
senior management experience to the HRB, 
his most recent role being that of chief 
executive of Molecular Medicine Ireland. He 
previously held a number of senior positions 
at Science Foundation Ireland, where he 
was responsible for the development of SFI’s 
2009–2013 strategy, Powering the Smart 
Economy, a €1.1 billion plan to drive delivery 
of the government’s enterprise science 
agenda, and its successor, Agenda 2020. 
Graham was chief executive of Multiple 
Sclerosis Ireland between 2005 and 2006. 
Before that he spent almost a decade with 
management consulting firm Accenture. 
He graduated from University College 
Dublin with a BSc in Pharmacology in 1993, 
followed by a PhD in vascular cell biology 
in 1997.
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3Tony Duffin of ALDP spoke on behalf of the National 
Voluntary Drug Sector (NVDS), a representative body of 
voluntary drug services across the state which engages with 
the drugs task force structures and processes. The NVDS has 
identified four key issues regarding the implementation of 
the National Drugs Strategy:
 ■ Lack of a national representative body to oversee 
implementation: in principle, the newly established 
National Co-ordinating Committee will meet this need 
but to be effective it must be a real decision-making 
forum.
 ■ Role of drugs task forces needs to be refocused and 
reconstituted: the recent review addresses this need and a 
timeframe for implementing the recommendations needs 
to be put in place. Speaking from his own experience in 
ALDP, Duffin stressed the need for task forces to take an 
evidence-based approach to selecting services
 ■ Alcohol: what existing budget is there for alcohol and 
what budget will be transferred for the implementation 
of the combined drug and alcohol strategy? Duffin 
pointed out that the health costs of alcohol use far 
exceed tax receipts from the drinks industry. Also, what 
role is envisaged for the voluntary sector with regard 
to alcohol? Duffin pointed out that merging drug and 
alcohol policies will mean treatment options, including 
residential services, will have to be enhanced to ensure 
polydrug users are not excluded.
 ■ Funding: the cuts since 2008 have resulted in services 
being cut and this has had a real impact on service users. 
At ALDP much of the progress made over the last 15 
years is being lost and the service is ‘moving backwards’.
After coffee the conference heard four presentations on 
incorporating alcohol in prevention work.
Promoting community engagement in addressing 
alcohol issues 
Community action seeks to change collective rather than 
individual behaviour. Because it impacts on the environment, 
it is a universal approach. Mobilising a community to action 
on alcohol effectively anchors and maximises the work 
by actively involving local groups and exploiting existing 
networks. Anne Timoney of Community Action on Alcohol 
outlined the process, from introducing the concept to 
developing the action plan, implementing and evaluating. 
www.alcoholforum.org 
Ballymun community alcohol strategy
Titled A road to change: Ballymun Community Alcohol 
Strategy 2010–2016, the strategy aims to use a public 
health approach to reduce alcohol-related risk to the 
Ballymun community’s health, safety and well-being. Hugh 
Greaves, co-ordinator of the Ballymun LDTF, outlined the 
process whereby the strategy was developed, the principles 
underpinning the approach, and the contents – 41 actions 
across six pillars:
1. Supply reduction, availability and enforcement
2. Community awareness
3. Treatment and rehabilitation
4. Prevention and education
5. Harm reduction
6. Policy and research 
www.ballymunlocaldrugstaskforce.ie/
communityalcoholstrategy 
Galway City alcohol strategy
The Galway City strategy to prevent and reduce alcohol-related 
harm 2013–2017 focuses on four key areas – prevention; 
supply, access and availability; screening, treatment and 
support services; and research, monitoring and evaluation 
– and includes 40 associated actions. An annual action 
plan is developed, including commitments from a range 
of partners, groups and organisations for each proposed 
action, and, at the end of the year, a progress report is 
compiled. Among the achievements to date, Evelyn Fanning 
of HSE West highlighted increased public awareness of the 
issues, improved information and understanding of alcohol 
availability and advertising, and patterns of alcohol-related 
harm, and responses that have begun to have an effect on 
the level of alcohol-related problems.  
www.galwayalcoholstrategy.ie 
Hello Sunday Morning (HSM) initiative
HSM is a blogging website that encourages people to 
undertake a period of sobriety and reflect on the role alcohol 
plays in their life. Bloggers or ‘HSMers’ come from several 
countries but are predominantly Australians. They write blog 
posts, make videos and take pictures of their experiences as 
part of their participation. Ian Power of Spunout.ie described 
a study that aimed to conceptualise and evaluate the social 
impact of HSM. Analysis of the blog posts of 1,768 HSMers 
showed that over time they changed from being very self-
focused, considering their own drinking and the views of 
peers, to reflecting on the role of alcohol in their lives, to 
finally taking a broader view of the role of alcohol in society 
and ways to help and support others in their personal HSM 
experiences. www.hellosundaymorning.org 
National>Drugs>Strategy>Conference>(continued)
At the NDS conference: Gary Broderick, director Saol Project; Mel 
MacGiobúin, co-ordinator North Inner City Drugs Task Force; and 
Fergus McCabe, CityWide Drugs Crisis Campaign
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4Supporting local efforts to tackle  
drug problems
On 23 January 2014 the new National Co-ordinating 
Committee for Drug and Alcohol Task Forces (NCC) held its 
inaugural meeting. Its purpose is to guide the work of the 
task forces and drive implementation of the National Drugs 
Strategy 2009–2016 (NDS) locally. It is the successor to the 
Drugs Advisory Group, established under the NDS,1 and to the 
National Drugs Strategy Team, which was incorporated in the 
2001–2008 national drugs strategy.2 
The following account is based on a presentation given by 
Susan Scally, head of the Drugs Policy Unit in the Department 
of Health, at the half-day conference on Ireland’s National 
Drugs Strategy (NDS), which is described elsewhere in this 
issue of Drugnet Ireland.3
Terms of reference for the NCC 
 ■ drive implementation of the NDS at local and  
regional level,
 ■ oversee, monitor and support the work of the task  
forces and to ensure that policy on drugs is informed  
by their work,
 ■ monitor implementation of NDS actions specific to drug 
and alcohol task forces,
 ■ monitor the expenditure and activities of the task forces 
and of drugs projects in their areas, and
 ■ make recommendations to the minister in relation to the 
implementation of the NDS and effective co-ordination 
of service delivery at local and regional level.
Membership of the NCC
 ■ Statutory sector: Department of Health, HSE, An Garda 
Síochána, Justice, Equality and Defence, Revenue Customs 
Service, Children and Youth Affairs, Education and Skills, 
Environment, Social Protection, Community and Local 
Government, Local Government Management Agency, 
Probation Service, Education and Training Boards
 ■ Community sector: two representatives
 ■ Voluntary sector: two representatives
 ■ LDTF Chairs Network: two representatives
 ■ LDTF Co-ordinators Network: two representatives
 ■ RDTF Chairs Network: two representatives
 ■ RDTF Co-ordinators Network: two representatives
Role of NCC in supporting local efforts to tackle the  
drug problem
 ■ brings together local and regional drugs task forces, 
key government departments and agencies and the 
community and voluntary sector,
 ■ roles and responsibilities of members clearly set out to 
encourage optimum participation,
 ■ strengthened accountability and feedback mechanisms,
 ■ opportunities for sharing best practice, and
 ■ more outcomes focused. 
New terms of reference for task forces
 ■ implement the NDS in the context of the needs of the 
region/local area,
 ■ support and strengthen community-based responses to 
drug misuse,
 ■ maintain an up-to-date overview on the nature and 
extent of drug misuse in the area/region,
 ■ identify and report on emerging issues and the 
development of proposals on policies or actions  
needed to address them,
 ■ promote the implementation of local/regional drug 
strategies, and 
 ■ monitor, evaluate and assess the impact of the funded 
projects and their continued relevance to the local/
regional drugs task force strategy and to recommend 
changes to the funding allocations as deemed necessary. 
NCC support for task forces in change process  
will include
 ■ adoption of their new terms of reference,
 ■ criteria for membership and tenure of members,
 ■ measures to strengthen governance and decision making,
 ■ monitoring and reporting arrangements, and
 ■ supporting local services to achieve quality standards in 
the delivery of services.
Minister’s bilateral meetings 
According to Susan Scally, the above changes were the 
outcome of a review of drugs task forces and national 
structures decision completed in 2012,4 and a subsequent 
series of bilateral meetings between Minister of State White 
with his counterparts in other government departments, 
with statutory agencies, and with representatives of the 
community and voluntary sectors and the regional and local 
drugs task forces. Ms Scally listed the key strategic issues to 
emerge from these bilateral meetings as follows:
Supply reduction
•	 Garda and Revenue Customs Service joint operations 
result in significant seizures of drugs. 
•	 Significant seizures of new psychoactive substances 
by Customs; shift to internet outlets is an emerging 
challenge.
•	 Drug-related Intimidation Reporting Programme is an 
ongoing partnership between gardaí, Family Support 
Network and HSE.
•	 An inspector in every Garda division is to target adults  
in the drug trade who use children to run drugs.
Education and prevention
•	 90.2% of children sit Leaving Certificate, which is 
regarded as a protective factor.
•	 Outcomes-focused Children and Youth Strategy 
Framework is in final stages of development.
drugnet>
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Drug strategy to be evaluated 
In December 2013 the Home Office published an evaluation 
framework,1 developed to assess the effectiveness and value 
for money (VFM) of the English and Welsh Drug Strategy 
2010, which expires in 2015.2 
Reason for the evaluation
While noting that data are available to monitor trends in 
drug use and also the numbers leaving drug treatment drug 
free, the evaluation framework document argues, ‘… it is not 
sufficient only to consider changes in these data as this does 
not enable us to attribute changes, whether they be good or 
bad, to the effects of the Strategy (i.e. we would not be able 
to prove that it was the Strategy that caused any changes 
in drug use or recovery)’ (p.8). The document goes on to 
state that, in order to robustly assess the effectiveness of the 
drug strategy in meeting its aims, it is necessary to evaluate 
the impacts of the programmes and interventions being 
undertaken as part of the strategy.
The scope of the evaluation
The Home Office states that the evaluation must be 
capable of assessing whether the drug strategy has met the 
overarching objectives and aims contained in the strategy 
document. While these are non-quantitative and aspirational, 
the Home Office argues that value for money will have been 
achieved if the money spent on tackling drug use is less than 
the monetised benefits resulting from the drug strategy (see 
accompanying figure).
How will the evaluation be undertaken?
The framework document outlines the steps in the 
evaluation, some of which have already been completed.
1. Drug-related programmes and interventions have been 
divided into five activity groups, each of which links 
to one or more of the objectives and aims set out in 
the 2010 drug strategy and where common aims and 
measurement can be applied. The five groups are early 
interventions, education and information approaches, 
treatment, non-treatment rehabilitative activity, and 
enforcement. A ‘logic model’ has been developed for 
each of these activity groups, outlining how they should 
operate to achieve their aim.3
2. A meta-evaluation approach4 will be used to combine 
the results from different evaluations within each activity 
group. Where sufficient evidence is available, separate 
VFM estimates will then be calculated for the five activity 
groups. The Home Office acknowledges that there are 
considerable gaps in evidence, and states that one of the 
intentions of the evaluation is to stimulate debate about 
how to fill these gaps. 
 Source:  HM Government (2013) Drug strategy 2010 
evaluation framework, p.8
•	 30% of children live with parental alcohol substance 
misuse.
•	 Supports for children and young people at risk in high-
support settings (assessment, consultation and therapy 
service) – HSE, Irish Youth Justice Service.
Treatment
•	 Nationwide access to treatment services:
 -  Almost 100% of over-18s access treatment within 
one month;
 -  Almost 100% of under-18s access treatment within 
one week.
•	 Probation Service works with prison, gardaí and 
treatment services to intervene with clients with 
substance misuse problems.
•	 Three main health issues affecting prisoners are mental 
health, poor physical health and drug addiction.
•	 Expansion of drug treatment (including methadone 
treatment) and other health and social services in prisons 
and in-reach services as required. 
•	 Protocol in place for seamless provision of treatment 
services between prison and the community.
•	 Drug treatment in prisons contributing to a reduction in 
the incidence of post-release overdoses.
Rehabilitation
•	 Very positive feedback from National Drug Rehabilitation 
Implementation Committee (NDRIC) evaluation; drugs 
task forces played a key role.
•	 National roll-out of NDRIC is planned.
•	 Issue with take-up of places on drug-specific Community 
Employment (CE) schemes; an advisory committee under 
aegis of Department of Social Protection is examining the 
model.
1.  Department of Community, Rural and Gaeltacht Affairs 
(2009) National Drugs Strategy (interim) 2009–2016. Dublin: 
Department of Community, Rural and Gaeltacht Affairs, 
paragraph 6.50. www.drugsandalcohol.ie/12388/ 
2.  Department of Tourism, Sport and Recreation (2001) 
Building on Experience: National Drugs Strategy 2001–2008. 
Dublin: Stationery Office, Dublin, paragraphs 3.6.4–3.6.5 
and Actions 85–91. www.drugsandalcohol.ie/5187/ 
3.  Susan Scally’s presentation is available at  
www.drugs.ie/multimedia 
4.  Department of Health (2012) Report on the review of drugs 
task forces and the national structures under which they 
operate. Dublin: Department of Health.  
www.drugsandalcohol.ie/19054/ 
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63. Having gathered data and estimated direct government 
spend on tackling drug use for each of the five activity 
groups, the direct return on investment (RoI) will 
then be assessed. This will be more difficult for some 
interventions than for others. For example, it has long 
been problematic to identify the drug-related proportion 
of enforcement spend (such as police activity), and of the 
spend for interventions which are not specifically aimed 
at drug users, such as early interventions. The evaluation 
framework document discusses how it proposes to tackle 
these challenges in some detail. 
4. Both drug-specific benefits and wider benefits relating 
to health, crime and employment will be identified 
with the help of the logic models. The scale of these 
benefits, and the extent to which they were caused by 
Drug Strategy 2010, will then be evaluated. Evaluating 
benefits will be made more complex in certain areas, 
such as the non-treatment rehabilitative activity group, 
due to the outcomes and benefits of one intervention 
likely overlapping with the outcomes of another. Any 
overlap will need to be recognised and benefits shared 
appropriately across the activity groups.
The evaluation of national drug strategies has been the 
subject of considerable debate across Europe and the 
international drug policy community.5 In the introduction 
to this evaluation framework document, the Home Office 
stresses that evaluating the drug strategy is a work in 
progress, a learning experience, which is likely to evolve  
as new information and evidence emerge. 
(Brigid Pike)
1.  HM Government (2013) Drug strategy 2010 evaluation 
framework – evaluating costs and benefits. London: Home 
Office. www.gov.uk/government/uploads/system/uploads/
attachment_data/file/265393/Drug_Strategy_Evaluation_
Framework_FINAL_pdf.pdf. This document defines VFM as 
‘the societal return on investment at a national level’ (p.8).
2.  HM Government (2010) Drug strategy 2010 reducing 
demand, restricting supply, building recovery: supporting  
people to live a drug free life. London: Home Office.  
https://www.gov.uk/government/publications/drug-
strategy-2010--2
3.  According to the Drug strategy 2010 evaluation framework, 
‘Logic models describe the theory, assumptions and evidence 
underlying the rationale for a policy, by linking the intended 
outcomes (both short and long-term) with the policy inputs, 
activities, processes and theoretical assumptions’ (p.12).
4.  According to the Drug strategy 2010 evaluation framework, 
meta-evaluation is ‘the synthesis of results from individual 
evaluations falling within the same activity group (e.g. 
enforcement), to provide an overall estimate’ (p.11).
5.  See Pike B (2010) Evaluating national drugs strategies. 
Drugnet Ireland, (34): 12–13.  
www.drugsandalcohol.ie/13295/ 
Dáil debate on cannabis
For the first time since 2006, Irish politicians have had a full 
debate on the drugs issue, specifically on a private member’s 
motion to regulate the cultivation, sale and possession of 
cannabis and cannabis products.1 They voted 112 to 8 in 
favour of a government amendment that recognised the health 
risks associated with cannabis and its role as a ‘gateway’ drug, 
recognised that leniency in cannabis control could endanger 
overall international efforts against drugs, to which Ireland is 
signed up under the 1961 and 1971 UN drug conventions, 
and endorsed current government policy ‘to maintain strict 
legal controls on cannabis and cannabis products in Ireland’. 
In the next section what politicians said is described, and 
in the following two sections, recent research, analysis and 
commentary relevant to the processes of drug policy debate 
are discussed.
(1) What did the politicians say? 
Individual deputies contributing to the debate raised 
three different options – prohibition, decriminalisation or 
regulation.2 The arguments made in favour of the various 
options were as follows:
Prohibition
 ■ The current system of strict controls and regulation of 
cannabis should continue because of the health and 
social risks associated with cannabis use.
 ■ Cannabis is a ‘gateway’ drug.
 ■ The balance of the greater good for society lies in 
continuing prohibition.
 ■ The current economic situation would preclude putting 
in place the measures to deal with the ‘excesses’ that 
would ensue if cannabis were legalised.
 ■ The benefits of legalisation would not exceed the costs.
 ■ Ireland would become an even bigger channel for the 
importation of illegal drugs to Europe.
 ■ Why reduce controls on drugs when controls on tobacco 
and alcohol are being strengthened? 
Decriminalisation
 ■ Need to stop using prison as a means to tackle the drug 
issue. Most drug users do not commit crimes except the 
crime of possession. 
 ■ Users found with small amounts of cannabis should not 
be criminalised or jailed, should not have convictions. 
 ■ In Portugal decriminalisation has led to a reduction in 
drug-related deaths, with no increase in drug prevalence. 
 ■ Decriminalising cannabis is a minimum step and a first 
step along the road in this debate. 
 ■ If cannabis were to be legalised, there is as yet no 
assurance that the drug gangs will be tackled or that 
enough treatment centres, mental health services and 
other supports needed will be provided.
Regulation 
Given that cannabis is freely available in Ireland and its use is 
normalised (over 7% of the population regularly use cannabis), 
the situation should be regulated so that cannabis users are 
not criminalised and criminals do not profit from the market 
in cannabis.
 ■ Public opinion supports regulation of the  
cannabis market.
 ■ The health risks have not been conclusively proven.
 ■ Regulation of recreational and medicinal cannabis use is 
happening elsewhere in the world.
Drug>strategy>to>be>evaluated>(continued)
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7(2) What could the politicians have said? 
The Dáil record of the recent debate on cannabis regulation 
indicates that while deputies acknowledge the importance of 
ensuring their policy arguments are consistent with scientific 
evidence, there is a need for more systematic and careful 
reading of the evidence, and more rigorous analysis of the 
policy options. 
Reading the evidence 
In referring to the scientific evidence, deputies both for and 
against the cannabis regulation motion tended to cite single, 
isolated items of research that supported their perception of 
the risks associated with using cannabis, particularly health-
related risks such as dependence, respiratory problems, lung 
and throat cancers, heart disease, strokes, epilepsy, a range 
of mental illnesses, impaired development in young people, 
and reduced fertility. Regarding the whole body of scientific 
evidence, four US public policy academics have argued in 
a recent publication:3 ‘The hard truth is that the scientific 
community has not reached a consensus on many of these 
questions so both sides of the legalization debate can refer to 
published studies that support their arguments and claim that 
the other side is ignoring the science. But the uncertainties 
are important.’ (pp.54–55; emphasis added.)
The authors identify two critical uncertainties: 
 ■ Marijuana is not a standardised commodity: The level 
of THC and other cannabinoids in the marijuana 
used by research subjects will vary and may influence 
the outcomes of interest; moreover, the amount of 
marijuana consumed by research subjects and over what 
time period will also vary, making it difficult to make 
comparisons across studies.
 ■ Causality as distinct from correlation: In many studies, it 
has proved difficult to determine conclusively whether 
marijuana caused the negative consequences or just 
happened to be correlated with them. 
Marijuana’s status as a ‘gateway drug’ is given as an example 
of ‘uncertainty’ with regard to causality. While young people 
who use marijuana, especially when they start at a young 
age, are statistically more likely to go on to use other drugs 
than their peers who do not use, the authors ask whether 
this means that marijuana causes the subsequent drug use or 
does it simply signal the risk of subsequent drug use, owing 
to other factors such as underlying social, psychological or 
even physiological factors. In a further twist of uncertainty, 
the authors also point out that because a causal connection 
is not needed to explain the observed correlation does not 
mean that there is no causal connection.  
In citing scientific evidence, the authors also advise that 
the validity and reliability of the research must be assured. 
Was the research design sound? Was the sample size large 
enough and the timespan of the study long enough to 
ensure reliable findings? Were appropriate analytical tools 
applied to the data?
Analysing the options
Expressing their personal preferences in the Dáil debate – 
for prohibition, decriminalisation or regulation – deputies 
generally justified their choice by pointing to risks that need 
to be avoided or to changing circumstances that need to be 
responded to. They tended not to explain their preference 
in terms of a policy framework or an overall rationale. In 
recent years, drug policy researchers have proposed a range 
of such frameworks and rationales, for example maximising 
the public good, treating the drugs issue as a governance 
rather than a criminal issue, or addressing the drugs issue as 
part of equality policy.4 The advantages of such frameworks 
are that they shift the debate away from the polarised and 
increasingly unproductive debate between prohibition on 
the one hand and legalisation/regulation on the other, and 
they also introduce an analytical rigour, which arguably leads 
to greater transparency and accountability.
To give an example of how an explicit policy framework can 
enhance the calibre of the policy debate by making explicit 
the logical underpinning: In the course of the Dáil debate, 
a number of deputies who were opposed to changing the 
law on cannabis raised a conundrum, why relax controls on 
illicit drugs when simultaneously strengthening controls on 
licit substances such as tobacco and alcohol? One possible 
answer has been provided by proponents of a public health 
and human rights-based policy framework as a basis for 
thinking about cannabis.5 Alcohol, tobacco and cannabis 
have all been available in unregulated markets, be they 
legal or illegal markets, with little regard to public health or 
human rights: to strengthen public health and human rights 
outcomes, all three markets should be strictly regulated by 
law (see graphic). 
What the ‘experts’ said
To underline the uncertainty and complexity of the issues 
around marijuana, the four US public policy experts whose 
work is discussed above took the unusual step of each 
writing their own conclusion to their joint book on the pros 
and cons of legalising marijuna.3 They all favoured a shift 
away from complete prohibition but varied in how far they 
would relax controls and how fast.
Hawken: ‘Given already widespread use among adults and 
kids, the enormous costs of marijuana prohibition, and the 
inconsistencies in our drug laws, it seems worthwhile to 
experiment with legalization in the United States. … [Having 
allowed for experimentation with different legal regimes at 
state level, and having adjusted taxes and controls on alcohol 
and tobacco markets] I would then support removing the 
federal ban on marijuana, and managing marijuana with 
regulations similar to those that apply to alcohol. This would 
mean strict licensing rules for production and sales, controls 
on advertising and product labelling, penalties for negative 
behaviours following use, and taxes high enough to avoid 
spikes in use.’ (p.236)
Dáil>debate>on>cannabis>(continued)
Source:  TDPF (2013) How to regulate cannabis: a practical guide, 
p.26.
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Caulkins: ‘I would vote against legalizing marijuana. Most 
of what people dislike about the current prohibition 
can be fixed by reforming prohibition and/or pursuing 
“middle path” options. Among middle path options, 
decriminalisation plus home growing and sharing (with or 
without user co-ops but without commercial production and 
sale) strikes me as having particular advantages for shrinking 
the black market.’ (p.238) 
Kleiman: ‘My first choice [among (1) prohibition, (2) 
decriminalisation, (3) permission to grow, (4) legalisation 
without commercialisation, (5) controlled commercialisation, 
and (6) lightly controlled commercialisation] is permission for 
production and use through small not-for-profit cooperatives, 
with a ban on commerce [i.e. option 4].’ (pp.243–4) 
Kilmer: ‘Whatever you do, incorporate a sunset provision. 
…Given the weak knowledge base, it is risky to implement 
the most extreme alternative to prohibition. …Incremental 
approaches that experiment with different combinations of 
activities relating to marijuana [i.e. (1) possession of small 
amounts, (2) non-profit production and sharing in private 
homes or small co-operatives, (3) retail sales, (4) commercial 
and/or government production, and (5) advertising and 
promotion] are inherently less risky than implementing them 
all at the same time.’ (pp.246–7)  
(3) Are politicians part of the problem  
or the solution? 
The two previous sections of this report on the recent Dáil 
debate on cannabis regulation discussed what was said in the 
debate, and how the deputies might have raised the calibre 
of their contributions. In this final section, recent research into 
how politicians can influence the development of drug policy is 
described. Several themes have emerged from this research:
 ■ Drug policy goals may be clearly enunciated but are they 
an accurate statement of what politicians really intend? 
Do all people, groups, agencies share a common view of 
the benefits and the harms associated with a specific drug 
policy? It is suggested that the motives of the ‘political 
élites’ that control the policy process are obscure, making 
it difficult to accurately assess whether their policies are 
succeeding or failing.6 
 ■ Concepts used to debate the drugs issue may not change 
over long periods but what is meant by the conceptual 
terms may well change. They are ‘political tools’ which 
can be manipulated to respond to changing moral 
climates and circumstances. The entrance of new actors 
into the policy debate, for example not only politicians 
but also experts, administrators and drug users, will 
influence the negotiation and agreement of shared 
conceptual understandings.7 
 ■ Language is the basis on which policy problems are 
constructed and represented. The resulting ‘discursive 
constructions’ have implications for how policy responses 
are understood and justified. By changing the language of 
policy, politicians can reframe the ‘problem’; for example, 
shifting from talking about drug use to drug harms, or 
away from talking about abuse or misuse can alter the 
impact of a drug policy.8
 ■ Grand narratives, comprising story lines and symbolic 
devices, are used by politicians to paint a picture of just 
what the ‘drug problem’ is at any particular time. The 
choice of issues is framed by a heady mix of evidence, 
moral and ethical values, ideologies, mass media 
coverage, public opinion and political opportunism. To 
achieve a more rational approach, in which evidence and 
logic prevail, ‘exceptional leadership’ is required and the 
drugs issue needs to be positioned in a broader policy 
context such as health, inequality or poverty.9
 ■ Political games The drug issue tends to be used as a weapon 
in political games, e.g. shoring up one’s own ideological 
position while undermining that of an opponent, and 
in electioneering. In such a political climate, scientific 
evidence and calm appraisal lose out, or are distorted by 
underpinning values and political interests.10 
Only twice have Irish politicians taken the wheel in 
formulating Ireland’s drug policy, in 1983/4 and 1996/7.11 
On both occasions, the Ministers of State tasked with 
developing government policy delivered the boldest, most 
radical and most innovative policy proposals in the history of 
Irish drug policy. Government strategies produced at other 
times, by teams of either ‘experts’ or government officials, 
have tended to be more conservative, consolidating existing 
policy positions, ‘building on experience’. Perhaps in 2016, 
when the current National Drugs Strategy expires and the 
task of drafting a combined drug and alcohol strategy arises, 
when the UN General Assembly holds its first Special Session 
(UNGASS) on drugs since 1998, and 20 years after the last 
ministerial task force on drugs was convened, it will be time 
for Irish politicians once again to take a turn at the wheel.
(Brigid Pike)
1.  Cannabis regulation: motion [Private Members] (2013, 
5–6 November) Parliamentary Debates Dáil Éireann (Official 
Report—Unrevised), Vol. 819/1, pp.91–111 & Vol. 819/2, 
pp.846–869.
2.  For a discussion of previous Dáil debates on the drugs issue, 
see Pike B (2012) Politicians and the drugs debate – six 
years on. Drugnet Ireland, (41): 10. www.drugsandalcohol.
ie/17272/, and Pike B (2006) Politicians and the drugs 
debate. Drugnet Ireland, (19): 16–17. www.drugsandalcohol.
ie/11285/. 
3.  Caulkins JP, Hawken A, Kilmer B and Kleiman MAR (2012) 
Marijuana legalization: what everyone needs to know. New 
York: Oxford University Press.
4.  For a brief outline of these frameworks, see Pike B (2012) To 
prohibit or not to prohibit – that is no longer the question. 
Drugnet Ireland, (41): 7–8.
5.  Transform Drug Policy Foundation (TDPF) (2013) How to 
regulate cannabis: a practical guide. London: TDPF. The 
authors set out a policy framework comprised of six broad 
aims: protecting and improving public health, reducing 
drug-related crime, improving security and development, 
protecting the young and vulnerable, protecting human 
rights, and providing good value for money. 
6.  Friedman SR, Mateu-Gelabert P and Rossi D (2012) Has 
United States drug policy failed? And how could we know? 
Substance Use and Misuse, 47(13–14): 1402–1405. 
7.  Edman J and Stenius K (2013) Conceptual carpentry 
as problem handling: the case of drugs and coercive 
treatment in social democratic welfare regimes. International 
Journal of Drug Policy, http://dx.doi.org/10.1016/j.
drugpo.2013.10.005; Houborg E (2012) The political 
pharmacology of methadone and heroin in Danish drug 
policy. Contemporary Drug Problems, 39(1): 155–192.
8.  Lancaster K and Ritter A (2014) Examining the construction 
and representation of drugs as a policy problem in Australia’s 
National Drug Strategy documents 1985–2010. International 
Journal of Drug Policy, 25(1): 81–87.
drugnet>
Ireland
9Dáil>debate>on>cannabis>(continued)
9.  MacGregor S (2013) Barriers to the influence of evidence 
on policy: are politicians the problem? Drugs: education, 
prevention and policy, 20(3): 225–233.
10.  Edman J (2013) An ambiguous monolith – the Swedish drug 
issue as a political battleground 1965–1981. International 
Journal of Drug Policy, 24(5): 464–470; Tieberghien J and 
Decorte T (2013) Understanding the science–policy nexus in 
Belgium: an analysis of the drug policy debate (1996–2003). 
Drugs: education, prevention and policy, 20(3): 241–248. 
11.  For detailed accounts of Ireland’s drug policy since the 
1960s, see Butler S (2001) Alcohol, drugs and health 
promotion in modern Ireland. Dublin: Institute of Public 
Administration, and Pike B (2008) Development of Ireland’s 
drug strategy 2000–2007. HRB Overview Series 8. Dublin: 
Health Research Board. www.drugsandalcohol.ie/11465.
Homelessness Oversight Group submits 
its first report
The first report of the Homelessness Oversight Group was 
recently released.1 The Group was established by the Minister 
for Housing, Jan O’Sullivan TD, in February 2013. Its role, as 
set out in the policy statement on homelessness launched 
by the minister on the same day, was to monitor and review 
progress on the housing-led approach to end long-term 
homelessness and need to sleep rough by the end of 2016.2 
This first report, based on consultations with representatives 
from 36 stakeholders, a review of Pathway Accommodation 
and Support System (PASS) data on homelessness in the 
period ending September 2013, and detailed consideration 
of relevant policy-related material, gives a realistic account 
of the major obstacles to achieving the 2016 goals and a 
detailed set of recommendations on how these obstacles can 
be overcome. 
Trends in homelessness
The Group acknowledges that changes to the methods 
of measuring homelessness over the last 10 years means 
it is difficult to track precisely what progress has been 
made in reducing either overall homelessness or long-term 
homelessness. However, they suggest that the indicators 
available point to progress being slow. In reviewing the 
available datasets, including the Counted in, 2008 estimates 
and Census 2011 and the PASS data, the authors signal 
that overall ‘it seems likely that no significant reduction in 
long-term homelessness had occurred between 2008 and 
2011. Rough sleepers are on an upward trend… [and] …
little change in the incidence of homelessness seems to have 
occurred in Dublin in recent years’ (pp.9–10). 
Obstacles to progress to securing permanent housing
The housing-led approach seeks to place homeless people 
in sustainable rented accommodation as a first step, and 
provides ‘floating supports’ at the request of the person 
being housed. Such supports may include assistance with 
social welfare enquiries, developing independent living skills 
or seeking help for addiction problems. The Group’s report is 
quite explicit in identifying the key obstacle to this approach 
as a structural one, centred on the lack of integration 
between two social policy and implementation areas – care 
and housing. This lack of integration is neatly encapsulated 
in the following extract from the report: 
…housing providers [i.e. local authorities, approved NGOs 
and the Department of Social Protection] have housing 
responsibilities which go well beyond the homeless and 
embrace a wide range of low-income households. … 
Their priority targets (such as families with children and 
elderly households) do not include the single adult males 
who make up the majority of the long-term homeless. 
Homeless agencies, by contrast, are more narrowly 
focused on provision of shelter, social supports and related 
health services to the homeless but also require access to 
long-term housing in order to meet what is the core need 
of their clientele – the need for a permanent home. …
they depend on housing providers since they themselves 
have little role in housing but they struggle to make 
successful claims for access in the light of the low priority 
accorded to their clientele in the wider system of housing 
allocations. (p.10)
Recommendations to overcome blockages
The report’s core recommendation is that a high-level team 
be set up and given responsibility for achieving the 2016 
objectives This Homelessness Policy Implementation Team 
would be part of the general housing policy section of the 
Department of the Environment, and supported by an 
implementation unit. It is proposed that the team would 
enter into service level agreements (SLAs) with approved 
housing bodies capable of accessing capital funding from 
the Housing Finance Agency to supply permanent housing 
units, and with agencies providing care and support for the 
homeless people when they are housed.
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Are the 2016 objectives attainable? 
The Group sets out four grounds on which the 2016 
objectives can be realised: 
 ■ The scale of homelessness is not insurmountable: an 
estimated 1,500–2,000 permanent housing units being 
made available over the next three years is not an 
unrealistic target given that the state currently provides 
an estimated 250,000 state-supported housing units.
 ■ There are many under-used housing units and related 
financial resources which could be used to tackle and 
reduce long-term homelessness.
 ■ Current expenditure on expensive short-term 
accommodation and shelter will be freed-up as  
the long-term homeless make the transition to 
permanent housing.
 ■ Services provided to meet the health and social care 
needs of homeless people have improved greatly since 
the early 2000s, providing a platform on which to build 
an infrastructure of care and support to sustain long-term 
tenancies when the supply of permanent housing  
is increased.  
Recent research3 found that the views of stakeholders in 
Ireland were in broad agreement with the international 
consensus that responses to homelessness involve more 
than just providing housing in the form of ‘bricks and 
mortar’. Effective responses need to include housing 
alongside appropriate support, especially for people with 
high-support needs. The present report concurs with these 
findings, stating: ‘As the long-term homeless are moved into 
permanent housing between now and 2016…services will 
need to follow them and provide necessary supports in new 
ways and in new contexts’ (p.4). 
(Martin Keane) 
1. Kennedy M, Langford S and Fahey T (2013) Homelessness 
oversight group (First report) 2013. Dublin: Dublin Region 
Homeless Executive. www.drugsandalcohol.ie/21105
2. Department of the Environment, Community and Local 
Government (2013) Homelessness policy statement. Dublin: 
Department of the Environment, Community and Local 
Government. www.drugsandalcohol.ie/19346
3. Pleace N and Bretherton J (2013) Finding the way home: 
housing-led responses and the homelessness strategy  
in Ireland. Dublin: Simon Communities of Ireland.  
www.drugsandalcohol.ie/20183 
Drug policy advocacy organisations  
in Europe
In December 2013 the EMCDDA published Drug policy 
advocacy organisations in Europe.1 Presenting the results 
of a mapping study of such bodies undertaken by Aileen 
O’Gorman of UCD, this paper describes how civil society 
organisations engaging in drug policy advocacy in Europe 
are today well organised, high-profile and impact-oriented. 
Their development has been driven by greater ease of 
communication (facilitated by new technologies) and the 
greater number of formal mechanisms through which 
policymakers can now be reached. 
Advocacy is defined in the paper as ‘…activities and actions 
with the intention of influencing decision-makers and with 
the aim of developing, establishing or changing policies and 
practices and of establishing and sustaining programmes 
and services’.2 Three main categories of drug advocacy, 
all perceived to be following a transformative strategy for 
achieving social justice, are described in the paper (p.4): 
 ■ self or peer advocacy undertaken by individuals and peer 
groups speaking out for themselves, and often associated 
with the rights-based agendas of disability and mental 
health activism;
 ■ professional advocacy undertaken by ‘helping professions’ 
speaking on behalf of a person or an issue, often seeking 
the removal of structural barriers hindering their 
constituency’s needs being met; and 
 ■ public policy advocacy seeking to effect change mainly 
through legislation and resource allocation. 
An additional distinction is drawn between case and cause 
advocacy, with case advocacy focusing on the needs 
of the individual and cause advocacy addressing social 
reform. Advocacy is also observed to intersect the realms 
of lobbying, interest groups and social movements, in 
terms of their shared aims of influencing public policy and 
resource allocation decisions, legislation, or both, though by 
different approaches.
Drug advocacy organisations are defined in the paper 
as bodies with a website-based internet presence that 
contains a clearly stated aim to influence drug policy. Of 
the 218 organisations identified across 30 countries, 69% 
operated on a national basis, around one-fifth (17%) had 
a local or regional remit and over one-tenth (14 %) had 
a European or international remit. The primary objectives 
of the organisations were found to be predominantly in 
the area of practice development and delivery (65%), 
with 26% advocating use reduction and 39% harm 
reduction approaches. Primary objectives in the field of 
legislative changes were pursued by the remainder, with 
23% in favour of control reduction and 12% calling for 
control reinforcement.
The organisations included in the study, including 11 in 
Ireland (see box), were found to be engaged in targeted 
activities, aimed at influencing the attitudes and opinions 
of the public and policymakers on drug service provision, 
drug controls, or both. These activities are grounded in 
aspirations for an improvement in the well-being of the 
individuals, groups or societies affected by drug use. The 
paper concludes that changes in the nature, methods and 
impact of advocacy in the drugs area are evolving against 
a backdrop of economic crisis. As drug services and law 
enforcement agencies come under increased financial 
pressure, it is considered likely that the number and type 
of policy actors engaged in advocacy will grow. Equally, as 
communities affected by drug problems experience renewed 
difficulties in providing services, an increased impetus to 
engage in advocacy may emerge.
Homelessness>group>reports>(continued)
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Drug policy advocacy organisations in Ireland
Ana Liffey Drug Project
Ballymun Youth Action Project
CityWide Drugs Crisis Campaign
Family Support Network
ICON (Inner City Organisations Network)
INEF (Irish Needle Exchange Forum)
Irish Penal Reform Trust
Jesuit Centre for Faith and Justice
Merchants Quay Ireland 
SAOL Project
UISCE (Union for Improved Services, Communication  
and Education)
Drug policy advocacy organisations in Europe is one of four studies 
published by the EMCDDA in its new series, ‘EMCDDA Papers’. 
Primarily targeting policymakers and specialists, the papers are 
designed as brief and timely web-based products on a variety of 
topics in the drugs field. To be published several times a year, the 
papers will cover all aspects of Europe’s drug phenomenon, from 
consumption and markets to health and social consequences 
as well as the responses of the EU and its member states to 
drug problems.
1.  European Monitoring Centre for Drugs and Drug Addiction 
(2013) Drug policy advocacy organisations in Europe. EMCDDA 
Papers. Luxembourg: Publications Office of the European 
Union. www.drugsandalcohol.ie/21063
2.  This definition was developed by the Vienna NGO Committee 
on Narcotic Drugs. This committee links non-governmental 
organisations (NGOs) with UN intergovernmental and 
international agencies involved in drug policy, strategy and 
control: the Commission on Narcotic Drugs (CND), the 
International Narcotics Control Board (INCB) and the United 
Nations Office on Drugs and Crime (UNODC). www.vngoc.org
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European research on risk factors  
for overdose
Opiates (both illicit and prescribed) continue to be a 
significant factor in many poisoning deaths, not only in this 
country (see article on p. 14) but also internationally. In 
international literature, poisonings are also known as drug-
induced deaths or overdose. Some of the key findings about 
opiate overdose in Europe are shown in the box below. 
 ■ There are 1.4 million problem opiate users in Europe.
 ■ There were 6,500 overdose deaths in 2011.
 ■ There were more than 70,000 overdose deaths during  
the first decade of the 21st century.
 ■ Overdose deaths represent 4% of all deaths in adult 
males aged under 40.
 ■ Half of all deaths in people who regularly inject heroin 
are attributable to overdose.
 ■ On average, heroin users who overdose report having 
experienced three overdoses. 
 ■ Many heroin users who survived an overdose did not 
perceive themselves to be at high risk of overdose,  
even though they had a history of overdose in the 
previous six months.
Sources: EMCDDA (2013)1 and Frisher et al. (2012)2
Several recent publications have looked at the risk factors for 
overdose and strategies for prevention.1,2,3
Risk factors
There are many, often inter-related, risk factors for fatal and 
non-fatal overdose. Recognition of these factors can help 
prevent the occurrence of overdose. Availability of opiates, 
route of administration, polydrug use, periods of abstinence 
and health of the user are some of the common factors.2,3 
Based on a comprehensive review of the literature,  
Frischer et al. (2012) identified and classified risk factors at 
three levels: individual, observers and organisational. The 
table below lists the individual risk factors. Observer risk 
factors relate to the perceived consequences of becoming 
involved, e.g. risk of arrest if police are called. Organisational 
risk factors relate to the availability and flexibility of the 
treatment, response to treatment and misuse of prescription 
drugs. Another resource in this area is the ORION Project.4 
This is an ehealth tool for assessing overdose risks factors and 
is available for download from http://orion-euproject.com. 
The literature points to several main areas for prevention, both 
to reduce the risk of an overdose occurring and to prevent 
fatality in the event of an overdose. 
Overdose prevention information and training
The literature shows that problem opiate users often 
underestimate their risk of overdose1 so information, 
counselling and training to recognise the risks for, and signs 
of, overdose is vital. This information, along with training in 
basic cardio-pulmonary resuscitation, should also be provided 
to family and friends. 
Treatment
Access to, and retention in, treatment, including opiate 
substitution treatment, is one of the best ways to reduce 
opiate-related deaths.1,2,3
Co-ordinated release from prison
The increased risk of death from overdose in the first weeks 
after release from prison is well documented.5 Strategies to 
reduce this risk include increasing the availability of drug 
treatment in prison, pre-release counselling and overdose 
prevention information, co-ordination with the community 
to ensure continuity of treatment, and availability of social 
supports on release. 
 
drugnet>
Ireland
12
Reducing the availability of opiates
The United Nations Office on Drugs and Crime (UNODC) 
notes the rise in the number of overdose deaths owing to 
prescription opiates, particularly in the US.3 It recommends 
specific strategies, including real-time monitoring of the 
prescription of opiates, reduced prescribing, and promoting 
greater awareness among health professionals of the risks of 
long-term prescribing for chronic conditions. 
Preventing fatalities in the event of an overdose
Take-home naloxone is already available in five European 
countries as part of their overdose prevention strategies (see 
article on p. 13). Of note, the most recent figures from the 
National Drug-Related Deaths Index (NDRDI) show that 
59% of all poisoning deaths in Ireland in 2011 involved 
more than one drug, in many cases a benzodiazepine 
along with one or more other substances.6 Naloxone is only 
effective in reversing opiate overdose and therefore a range 
of strategies is needed to prevent overdose deaths when 
polydrug use is prevalent.
Another prevention strategy is to improve bystander response 
by providing information and training to enable those on the 
scene to recognise and respond to the overdose. Naloxone 
can be administered by bystanders (family, friends or other 
drug users) if they are properly trained. 
The EMCDDA cites the availability of supervised drug 
consumption rooms which are targeted at a very specific 
group of users as another strategy to reduce fatalities in 
the event of overdose.3 Seven European countries have 
such facilities. They are usually integrated into a service 
which offers a range of other harm reduction, medical and 
social services. 
 
Conclusion
The issues involved in preventing overdose are summarised 
by Frisher et al. (2012): 
[T]here is evidence that many interventions may 
reduce overdose, particularly in settings where the 
drug user is in contact with treatment or emergency 
services. However, it is important to bear in mind the 
distinction between overdose prevention at the clinical 
and at the population level. At the clinical level, specific 
interventions are available and have been shown to 
be effective (e.g. pharmacological treatment). At the 
population level, where many drug users are not in 
contact with services, overdose reduction depends on 
behavioural change by drug users themselves (e.g. 
avoiding the mixture of opiates and other depressant 
drugs). Overdose prevention is a multifaceted problem. 
Purely technological interventions were thought likely 
to have a relatively limited impact. Rather, overdose 
involves personal and societal issues; only when these are 
addressed is the level of fatal overdose in Europe likely to 
decrease. (pp. 4–5)
(Suzi Lyons)
Individual risk factors for overdose
Drug use
•	 Topping up on a legitimate methadone prescription
•	 Using someone else’s methadone prescription
•	 Preferring illegal drug use to prescribed methadone
•	 Not always taking prescribed medication, which may 
reduce drug tolerance and increase withdrawals and 
susceptibility to overdose
•	 Unintentionally taking too many drugs, due to 
unexpected heroin purity, lower tolerance, or ingesting 
unknown tablets
•	 More frequent use of illicit methadone
•	 Very high levels of drug intake with users experiencing 
difficulty in controlling their drug intake
•	 High levels of polydrug use and prescription drug use
•	 Reduced tolerance to opioids
•	 Benzodiazepine use
•	 Large quantities of alcohol
•	 Injecting cocaine
•	 Length of time that people have used drugs
•	 Sporadic use of heroin
Experience of treatment
•	 Withdrawal from drug treatment
•	 Leaving treatment
•	 Periods of induction and transition, such as when 
drug users (re)enter or discontinue treatment
•	 Greater number of separate treatment episodes
Psychiatric/physical
•	 Suicidal ideation
•	 History of mental health problems, a current 
psychiatric diagnosis and prescription of psychotropic 
medicines
•	 Access to antidepressants, through genuine 
prescriptions, obtaining different antidepressants from 
different prescribers
•	 Feelings of indifference and carelessness
•	 High levels of hepatitis and cirrhosis
Circumstances of overdose
•	 Slow overdose onset
•	 Two weeks after release from prison (compared to other 
times of liberty)
Social
•	 More drug injectors in the social network 
experiencing conflict with more network members
•	 Life events: recently experienced bereavement of 
someone close to them, a relationship breakdown, 
accommodation problems
Circumstances
•	 Injecting drug use in public places affords less 
opportunity to test the sample strength
Reproduced from Frischer et al. (2012), p.17
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1.  European Monitoring Centre for Drugs and Drug Addiction 
(2013) Perspectives on drugs: preventing overdose deaths in 
Europe. Lisbon: EMCDDA. www.emcdda.europa.eu/topics/
pods/preventing-overdose-deaths
2.  Frisher M, Baldacchino A, Crome I and Bloor R (2012) 
Preventing opioid overdoses in Europe: a critical assessment 
of known risk factors and preventative measures. Lisbon: 
EMCDDA. www.drugsandalcohol.ie/18701 
3.  UNODC and WHO (2013) Discussion paper UNODC/
WHO 2013. Opioid overdose: preventing and reducing 
opioid overdose mortality. Vienna: United Nations. www.
drugsandalcohol.ie/20068 
4.  Lynn E (2014) The overdose risk information (ORION) 
project. Drugnet Ireland, (48): 14. www.drugsandalcohol.
ie/21212
5.  Lyons S, Walsh S, Lynn E and Long J (2010) Drug-related 
deaths among recently released prisoners in Ireland, 1998 
to 2005. International Journal of Prisoner Health, 6(1): 26–32. 
www.drugsandalcohol.ie/13332
6.  Health Research Board (2014) Drug-related deaths and deaths 
among drug users in Ireland: 2011 figures from the National 
Drug-Related Deaths Index. www.drugsandalcohol.ie/21005
Preventing opiate-related deaths in Ireland: 
the naloxone demonstration project
One of the key priorities of the Health Service Executive (HSE) 
National Service Plan 2014 is to improve health outcomes 
for people with addiction issues.1 One of the actions related 
to this is the finalisation of the implementation plan for 
the National Overdose Prevention Strategy (unpublished). 
Investigating the possibility of enhanced availability of 
naloxone, a drug used to counter the effects of opiate 
overdose, is a key element of the HSE’s overdose strategy 
(personal communication, Mr Joe Doyle, national planning 
specialist, HSE). This is important, considering opiates were 
implicated in 50% of all poisoning deaths in Ireland in 2011 
(see article on drug-related deaths on p.14 of this issue). 
The proposals on how to progress the naloxone 
demonstration project include: 
 ■ Identify stakeholders: to include a wide range of 
organisations, including community, families and 
voluntary services.
 ■ Product choice: e.g. pre-filled syringe or nasal 
formulation.
 ■ Legislative issues: naloxone is a prescription-only 
medication in Ireland and can only be dispensed by 
a pharmacist to a named person, for their use only, 
and can only be administered to that person by a 
trained healthcare professional (which includes certain 
ambulance service personnel).   
 ■ Cost and evaluation: to include pharma-economic 
evaluation, costs of training and supply of product. 
 
 
The Take Home Naloxone (THN) demonstration project 
started in Wales in 2009 is one of a number of UK models 
that have been documented.2 Its main aim was to reduce 
drug-related deaths in Wales and it incorporated an 
independent evaluation at the end of the first year. This 
project was possible because of a change in the legal status 
of naloxone in 2005 in the UK which allowed any member 
of the public to administer naloxone in an emergency. The 
project took place in six pilot sites. Drug users, their friends 
and families were trained in overdose prevention, including 
how to identify risks, how to administer naloxone, and basic 
cardiopulmonary resuscitation. The independent evaluation 
of the project found an important outcome was that those 
who had been trained did not rely only on naloxone but also 
used other life-saving measures that they had been taught 
by the programme; they more frequently used the recovery 
position and called an ambulance than those who were  
not trained. 
The project continues in Wales and has been expanded to 
different pilot settings. For example, in one major hospital 
emergency department, staff have been trained to give THN 
to clients at risk of overdose when leaving the hospital. For 
further information see http://tinyurl.com/nkrxmvy
(Suzi Lyons)
1.  Health Service Executive (2013) National Service Plan 2014. 
Dublin: Health Service Executive. www.drugsandalcohol.
ie/21092
2.  Bennett T, Holloway K (2011) Evaluation of the Take Home 
Naloxone demonstration project. Merthyr Tydfil: Welsh 
Assembly Government. http://wales.gov.uk/docs/caecd/rese
arch/110627naloxonefinalreporten.doc
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Latest figures on drug-related  
deaths published
The latest 
national figures 
on drug-related 
deaths in 2011 
have been 
published.1 
The figures in 
this update 
supersede all 
previously 
published 
figures. 
Similarly, figures 
for 2011 will be 
revised when 
data relating to new cases become available.
In the eight-year period 2004 to 2011, a total of 4,606 
deaths by drug poisoning and deaths among drug users met 
the criteria for inclusion in the NDRDI database. Of these 
deaths, 2,745 were due to poisoning and 1,861 were deaths 
among drug users (non-poisoning) (Table 1). There were 
607 deaths in 2011, compared to 597 in 2010.
Poisoning deaths in 2011
The increase in the total number of drug-related deaths 
in 2011 is due entirely to an increase in the number of 
poisoning deaths, which rose from 338 in 2010 to 365 in 
2011 (Table 1). As in previous years, the majority (72%) were 
male. The median age of those who died was 39 years, again 
similar to previous years. 
In 2011, alcohol was, once again, the drug most commonly 
involved in poisoning deaths (37%); however, several new 
trends emerged. Over half (59%) of all poisoning deaths 
involved more than one drug (polydrug use), with a total 
of 215 cases, a 28% increase on the 2010 figure of 168 
Additionally, the number of deaths where prescription 
drugs were implicated increased sharply compared to 2010 
figures. The number of deaths where benzodiazepines were 
implicated increased by 61%, to 166 in 2011 compared to 
103 in 2010. There was also a steep increase in the number 
of deaths where antidepressant drugs were implicated, 
from 66 in 2010 to 96 in 2011. In addition, the number of 
deaths where methadone was implicated increased to 113, 
compared to 60 in 2010. 
The reasons behind these upward trends are not yet clear 
and further analysis is needed to begin to understand the 
factors involved. What is known is that there was no change 
in the methodology used by the NDRDI between 2010 and 
2011. What is also known is that 68% of those who died 
where methadone was implicated were not registered on 
the Central Treatment List (of people receiving methadone 
substitution treatment) at the time of their death. 
The number of poisoning deaths in which heroin was 
implicated continues to decline, falling by 17% to 60  
in 2011, compared to 72 in 2010. It is of note that  
similar trends were observed in Scotland during the  
same time period.2 
Non-poisoning deaths in 2011
The number of non-poisoning deaths recorded among drug 
users dropped for a second year, to 242, compared to 259 
in 2010 (Table 1). These deaths are categorised as being due 
either to trauma or to medical causes (Figure 1). 
Deaths due to trauma
The number of deaths due to trauma decreased in 2011, to 
117 deaths, down from 122 in 2010 (Figure 1). The majority 
(71%) of those who died were aged under 39 years. The 
median age was 29 years. As in previous years, the majority 
were male (86%).  The most common causes of death due 
to trauma were hanging and road traffic collisions.  Even 
though there has been a slight overall reduction in the 
number of traumatic deaths, it is notable that there has been 
a rise in the number of deaths due to hanging, from 49 
deaths in 2010 to 65 in 2011.
Deaths due to medical causes
The number of deaths due to medical causes decreased 
slightly in 2011 (Figure 1). The majority (60%) of those who 
died were aged between 30 and 49 years. The median age 
was 43 years. Males accounted for 76% of those who died. 
The most common medical causes of death were cardiac 
events and liver diseases.
(Suzi Lyons and Ena Lynn)
1.  Health Research Board (2014) Drug-related deaths and deaths 
among drug users in Ireland: 2011 figures from the National 
Drug-Related Deaths Index. www.drugsandalcohol.ie/21005 
2.  National Records Scotland (2012) Drug related deaths in 
Scotland in 2011. Edinburgh: National Statistics Scotland. 
www.gro-scotland.gov.uk/files2/stats/drug-related-
deaths/2011/drug-related-deaths2011.pdf
  2004 2005 2006 2007 2008 2009 2010 2011
All deaths 431 503 561 630 624 653 597 607
Poisoning (n=2,745) 267 300 326 389 386 374 338 365
Non-poisoning (n=1,861) 164 203 235 241 238 279 259 242
 
 
  2004 2005 2006 2007 2008 2009 2010 2011
Medical 55 68 103 114 121 132 131 125
Trauma 91 116 125 117 110 132 122 117
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Table 1 Number of deaths, by year, NDRDI 2004 to 2011 
(N=4,606)
Figure 1 Non-poisoning deaths among drug users, 
NDRDI 2004 to 2011 (N=1,779)
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NDTRS drug treatment data for 2011 and 
2012 available on line
Drug treatment data for 2011 and 2012 from the National 
Drug Treatment Reporting System (NDTRS) are now 
available in the DRUG DATA pages of the NDC website 
at www.drugsandalcohol.ie. The database now contains 
nine years of drug and alcohol treatment data that can 
be searched to produce customised reports. You can run 
analyses on the data based on up to eight different types of 
drug, and alcohol, in various combinations. The variables 
available for analysis include year, age group, gender and 
place of residence (county, HSE region, LHO, regional or 
local drugs task force area). The report of your analysis can 
then be exported into Excel. 
When interpreting the data, it should be remembered that 
each NDTRS record relates to a treatment episode (a case) 
and not to a person. Because there is currently no unique 
health identifier system in place in Ireland, the same person 
can be counted more than once in a reporting year if they 
had more than one treatment episode in that year.
Before using this resource you will be asked to accept a 
number of terms and conditions. These conditions protect 
the identity of NDTRS clients and the integrity of the data. 
We also ask that the NDTRS is acknowledged when data 
from the tables are used in a publication or presentation, and 
that the NDC and the NDTRS team both receive copies of 
any publication in which these data are used.
Stakeholder consultation on Hidden Harm 
‘Hidden harm’ (HH) is the term now most often used to 
describe the experience of children living with, and affected 
by, problem alcohol and other drug use by parents. The 
term conveys the two key features of that experience: these 
children are frequently not known to health or social services, 
and they are exposed to harm, often through physical or 
emotional neglect.1,2,3 Experience from other countries has 
shown that despite evidence to show the negative impact 
of HH, there is lack of policies on how to effectively address 
HH. The other two main areas where HH is of concern are 
domestic violence and parental mental health disorders.
In June 2013 a project management steering group on 
hidden harm was established, led by the National Social 
Inclusion Office, Mental Health and Addiction Services North 
West, and the new Child and Family Agency. 
The group has already identified two national practice sites, 
Donegal and the Midlands, to begin HH practice working, 
with the initial focus on the needs of children and families 
where there is parental problem alcohol and/or other drug 
use. The overall aim is to raise awareness and to work 
with children affected by HH but also to develop a HH 
protocol to ensure the welfare and protection of children 
through interagency working aimed at early identification 
and support.
As part of this process, a stakeholder consultation meeting 
took place on 28 January 2014 in Sligo. The aim of this 
consultation was to learn from the experience and practice 
of those currently working in the area, including health, 
social work, and drugs and alcohol services across the two 
national practice sites, in order to inform the strategy for HH 
nationally and also to contribute to the current policy and 
practice debate in this sensitive and difficult area. 
The objectives of the consultation were to:
 ■ promote open dialogue on appropriate responses to 
children and families whose lives are affected by drug 
and alcohol use;
 ■ gain a baseline understanding of awareness pertaining to 
HH among practitioners;
 ■ draw on the views and experiences of stakeholders;
 ■ inform the current practice debate on HH;
 ■ identify current practice in responding to HH; 
 ■ identify practice issues that may pose a barrier to 
addressing HH; and
 ■ inform the development of a national practice guide for 
addressing HH. 
The meeting was opened by Ms Marion Rackard, National 
Social Inclusion Office, followed by a welcoming address 
from the chair, Mr Fred McBride, newly appointed chief 
operations officer of the newly created Child and Family 
Agency. He spoke about three key objectives for the 
HH process: a clear policy direction; joint integrated 
protocols; and political ownership of the parameters of risk 
management. Then Mr Joe Doyle, National Social Inclusion 
Office, gave a comprehensive overview of the background 
to the national policy documents which had led to this 
initiative. This was followed by a presentation by Dr Aisling 
Gillen of the Child and Family Agency in which she explained 
the rationale behind the focus on HH. She outlined the 
key elements built into the HH steering group action plan, 
including supporting practitioners and partnerships for 
cohesive working relationships; the need to develop national 
practice guidelines on addressing problem parental alcohol 
and other drug use; and the need to develop a framework 
for delivering on HH inclusive of a national strategy, protocol, 
suggested performance measures and monitoring processes. 
Dr Joy Barlow OBE (pictured) gave a powerful presentation 
about the Scottish experience, including mistakes made 
and lessons learnt. She spoke about the importance of 
early identification of children at risk, the need to estimate 
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numbers, the importance of staff training and development, 
and partnership. She also noted that, based on the Scottish 
experience, Ireland now had an opportunity to act given the 
priority problem alcohol use now has. She stated that the 
2011 report Hidden realities provides baseline data on the 
number of children affected by parental alcohol use.4 
Presentations by speakers from Northern Ireland followed, 
from Ms Cathy Mullan and Mr Davis Turkington, both from 
the HH Public Health Agency, and Ms Cathy Comiskey, 
child and family liaison practitioner. They gave very useful, 
interesting and practical accounts of how they had worked 
through the process of developing a protocol, setting out 
roles and responsibilities, implementing policies and how this 
all works in reality.5,6 Videos and powerpoint presentations 
delivered on the day are available at www.drugs.ie/features. 
This was followed by a facilitated structured round-table 
discussion among those attending the meeting, addressing 
a series of questions, the outcome of which will inform the 
ongoing process.
There are two more consultations planned to feed into  
this process: 
 ■ Phase 2: Views of families 
 ■ Phase 3: Views of commissioners, managers, practitioners 
and researchers working in health, social work, and drugs 
and alcohol services and other relevant departments,  
e.g. justice
The Substance Misuse and Child Welfare Special Interest 
Group in Northern Ireland is a forum for those interested in 
this area, and is now open to all practitioners both North and 
South. The aim of the group is to:
 ■ share and discuss the implications of research findings;
 ■ disseminate developments in policy and practice;
 ■ promote the evidence base informing policy and practice 
developments; and
 ■ network and share resources.
Members will receive regular updates through a Listserv 
mailing list and seminars will be organised. To become an 
email member contact David Hayes at d.hayes@qub.ac.uk
(Suzi Lyons)
1.  Advisory Council on the Misuse of Drugs (2003) Hidden 
harm: responding to the needs of children of problem drug 
users. London: Advisory Council on the Misuse of Drugs. 
www.drugsandalcohol.ie/5456
2.  Scottish Executive (2004) Hidden harm: Scottish Executive 
response to the report of the inquiry by the Advisory Council on 
the Misuse of Drugs. Edinburgh: Scottish Executive. www.gov.
uk/government/uploads/system/uploads/attachment_data/
file/120619/0012816.pdf
3.  The Council of Australian Governments (2009) Protecting 
children is everyone’s business: national framework for protecting 
Australia’s children (2009–2020). Canberra: Commonwealth of 
Australia. www.communities.qld.gov.au/resources/childsafety/
child-protection/national-framework.pdf
4.  Hope A (2011) Hidden realities: children’s exposure to risks 
from parental drinking in Ireland. Letterkenny: North West 
Alcohol Forum. www.drugsandalcohol.ie/16250
5.  Public Health Agency, Health and Social Care Board (2009) 
Hidden harm action plan: responding to the needs of children 
born to and living with parental alcohol and drug misuse 
in Northern Ireland. Belfast: Department of Health, Social 
Services and Public Safety. www.drugsandalcohol.ie/15570
6.  Public Health Agency, Health and Social Care Board (2013) 
Regional Joint Service Agreement – Hidden Harm protocol. 
Belfast: Public Health Agency, Health and Social Care Board.
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Investigating the links between 
substance misuse and crime among 
young offenders 
A better understanding 
of the nature of the 
connection between 
drug use and offending 
has implications 
for drug and crime 
prevention and for 
treatment and criminal 
justice interventions.1 
A major impediment 
in this area in Ireland, 
however, is the absence 
of research and data 
from within the 
criminal justice system. 
Although annual data 
are available from the 
Central Statistics Office 
and the Courts Service on the number of drug offences 
(infringements of drug laws such as possession and supply) 
that are committed, and from the Irish Prison Service on the 
number of prison committals for drug offences, data are not 
routinely available on the number of drug-related offences 
committed as a consequence of substance misuse, whether 
alcohol-related public order offences or thefts committed by 
dependent drug users to feed their drug habit, for example. 
The development of a knowledge base of this kind often 
requires further analysis of the data compiled within agencies 
of the criminal justice system. 
In 2012, the Probation Service published the findings of 
the first large-scale, nationwide survey of drug and alcohol 
misuse among the adult offender population on probation 
supervision,2 followed in late 2013 by the report of a similar 
survey of young offenders (aged 20 years or under) who 
were on probation supervision.3  
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The main objectives of the latter survey were: 
 ■ to determine the number of young offenders under 
probation supervision who had misused drugs and/or 
alcohol;
 ■ to investigate the nature and frequency of drug and 
alcohol misuse;
 ■ to examine the context within which drug and alcohol 
misuse occurred;
 ■ to ascertain whether a relationship exists between drug 
misuse and offending behaviour and alcohol misuse and 
offending behaviour;
 ■ to identify the range and nature of engagement with 
drug and alcohol treatment services. (p.9)
The survey population was identified by means of the 
Probation Service electronic case tracking system. Probation 
officers completed and returned survey questionnaires 
relating to 721 offenders on their casebooks on 3 December 
2012, of whom 647 (89.7%) were male and 74 (10.3%) 
were female. 
Of the 721 cases surveyed, 628 (87%) were identified as 
having misused drugs, alcohol or a combination of both; 
12% had misused drugs only, and 12% had misused alcohol 
only. Male and female offenders had relatively similar rates 
of substance misuse. Alcohol was the substance most often 
misused on a weekly basis (39.8% of males and 43.6% of 
females), followed by cannabis (20.4% of males, 14.5% 
of females). Females were ‘less likely to have misused both 
drugs and alcohol and significantly less likely than males 
to have misused drugs alone (1%). However females were 
more likely than males to have misused alcohol only (16% 
compared to 12%)’ (p.17). Twenty-six per cent of females 
were reported to have abstained entirely from either drug 
or alcohol abuse, compared to 11% of males. A higher 
percentage of females (14.5%) than males (8.9%) misused 
prescription drugs (p.20). 
The study also explored the ‘gateways and influences’ 
which surround the misuse of drugs and alcohol by young 
offenders. Alcohol was recorded as the most common 
substance first misused, followed by cannabis. A higher 
percentage of females than males were reported to have 
started with alcohol (females 70.9%, males 55.7%), while 
cannabis as the first substance used was higher for males 
(males 35.3%, females 23.6%). While substance misuse was 
reported as commencing as young as 9 years, the median 
age was 14 years. Consistent with most other studies in this 
area, more than 80% of offenders first engaged in substance 
misuse with their peers. Of the 628 offenders who had 
misused a substance, 38.9% had parents with a history of 
substance misuse, while 55.6% did not. In explaining this 
phenomenon, and citing a UK study, the report states that 
‘alcohol consumption in Great Britain and Ireland can only 
be appreciated in the context of a “wet culture”, whereby 
young people’s drinking is essentially “normal” behaviour, 
part of a wider socialisation process, reflecting adult 
practices’ (p.25).
With regard to the link between substance misuse and crime, 
in more than 80% of cases substance misuse was linked, in 
the professional opinion of the probation officer, to current 
offending. Alcohol was the substance most frequently linked 
to offending for 61.7% of females and 43.8% of males. Drug 
misuse on its own was linked to a relatively small amount 
of offending. Public order was the most common offence 
category linked to offending and ‘in nearly 70% of those 
cases alcohol was the substance of misuse’ (p.30). In cases 
of assault, over half of the cases identified alcohol as the 
substance of misuse. Again, these findings are consistent 
with those of earlier Irish research in this area.4 Over half of 
the survey population had attended some form of drug/
alcohol treatment, the majority of whom were aged between 
18 and 20 years.
One of the key performance indicators under the 
research/ information pillar of the current drugs strategy 
is comprehensive and timely reporting systems for the 
‘progression of offenders with drug-related offences through 
the criminal justice system’.5 Action 55 proposes as an area of 
research ‘the impact of alcohol and drugs on the Irish health 
and justice systems’. This initiative by the Probation Service 
makes an important contribution in this respect.
(Johnny Connolly)
1.  For a general discussion see Connolly J (2006) Drugs and 
crime in Ireland. HRB Overview Series 3. Dublin: Health 
Research Board.
2. Martyn M (2012) Drug and alcohol misuse among adult 
offenders on probation supervision in Ireland: findings from the 
drugs and alcohol survey 2011. Navan: The Probation Service. 
www.drugsandalcohol.ie/18746. See also Connolly J (2013) 
Investigating the links between substance misuse and crime. 
Drugnet Ireland, 45: 15. 
3. Horgan J (2013) Drug and alcohol misuse among young 
offenders on probation supervision in Ireland. Navan: The 
Probation Service. www.drugsandalcohol.ie/21333
4.  Institute of Criminology (2003) Public order offences in 
Ireland: a report by the Institute of Criminology, Faculty of 
Law, University College Dublin for the National Crime Council. 
Dublin: Stationery Office. www.drugsandalcohol.ie/5437
5.  Department of Community, Rural and Gaeltacht Affairs 
(2009) National Drugs Strategy (interim) 2009–2016.  
Dublin: Department of Community, Rural and Gaeltacht 
Affairs. (p.97). 
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Problem solving justice – establishing  
a community court in Dublin
The Dublin 
City Business 
Association (DCBA) 
has called for the 
establishment 
of a community 
court as a means 
of addressing 
low-level crimes 
such as vandalism, 
theft, anti-social 
behaviour, drug use 
and drug dealing 
in the capital. 
Addressing a seminar organised by the DCBA in January 
2014, its CEO David Brennan said: 
We seek a system that manages the individual and not 
the process. We envisage a non-adversarial justice system 
that deals with the underlying causes of the offences and 
seeks to help the person and provide relevant support 
services to the perpetrators of these low level crimes and 
reduce reoffending. We ask the Government to consider 
establishing a working committee to establish a pilot for 
Community Courts in the capital.1 
The seminar also heard presentations from Julius Lang of 
the Centre for Court Innovation in New York and from Phil 
Bowen of its affiliate organisation in the UK.2 Following 
the seminar both speakers addressed the Joint Oireachtas 
Committee on Justice, Defence and Equality which had 
convened a meeting to discuss the feasibility of introducing 
such a community court system.3
There are currently more than sixty community courts in 
operation internationally, mostly in the United States where 
they began, but more recently in South Africa, England, 
Wales and Scotland, Australia and Canada.4 In a 2007 
report making the case for community courts in Ireland,5 
the National Crime Council (NCC) recommended the 
establishment of such a court in Dublin’s inner city to deal 
with ‘quality of life offences committed in the Store Street 
and Pearse Street Garda station catchment areas’ (p.7). 
Community courts, sometimes called community justice 
centres, have a number of common characteristics that 
differentiate them from traditional courts. In particular, 
according to the NCC report, community courts:
 ■ are designed to help defendants to solve the problems 
that underlie their criminal behavior;
 ■ hold them to account for the specific incidents that 
brought them to court;
 ■ consult with the local stakeholders to set and  
accomplish priorities;
 ■ are pro-active in preventing crime rather than merely 
responding when crime has occurred;
 ■ bring the criminal justice agencies (courts, prosecutors, 
defence lawyers and police) into close co-ordination to 
address community issues; and
 ■ strive to create an atmosphere which is conducive to 
engaging communities. (p.16)
With regard to the last objective, community courts are 
normally located in a particular locality and their jurisdiction 
is limited to that neighbourhood. They are presided over 
by a dedicated judge who, as a consequence, can develop 
an in-depth understanding of the problems in the area and 
a familiarity with local stakeholders,supports and services. 
The logic behind this approach was explained by Julius Lang 
in describing to the Oireachtas Committe the setting up of 
the first community court in Times Square, New York, in the 
early 1990s. The crime problem facing Times Square was ‘a 
combination of complex social, economic, health and other 
issues and, as such, it defies easy solutions. … It was a type 
of crime that did its damage through an accumulation of 
relatively small but constant insults to the social fabric’ (p.3). 
Times Square had become a ‘mecca for the small and ugly, 
including street prostitution, open-air drug dealing, drunken 
brawling, assaults, shoplifting and illegal street trading’ (p.4). 
The model adopted in response was
a court with a geographic focus which would harness the 
power of the justice system to work with the community 
to solve local problems. …typical punishment consists of 
a combination of a community restitution assignment and 
mandated social services. These responses are delivered 
quickly, not days or weeks after the fact, often on the same 
day or next day after sentencing. (p.4)
Evaluations of community courts have provided mixed 
results. Philip Bowen, in his presentation to the Oireachtas 
Committee, explained that various evaluations have found 
that community courts can lead to reductions in the use of 
jail sentences, increased compliance with community-based 
court orders, decreases in crime such as prostitution and 
illegal street trading and positive cost-benefit outcomes. On 
the other hand, the recent closure of the North Liverpool 
Community Justice Centre was prompted by the low 
caseload coming before the court and the finding that the 
project did not reduce re-offending at any greater a rate 
than the UK average.4
In advocating the establishment of a community court in 
Dublin, the NCC recommend that its remit should primarily 
involve responding to public order offences, most of which, 
the evidence shows, are alcohol related.6 In response to 
drug-related offences, a community court could also function 
as a gateway to treatment services, or indeed, to the Drug 
Treatment Court, which has been operating in the city for 
many years. Substance-related crime and anti-social behavior 
in Dublin city centre is not a new phenomenon, but it is one 
that has attracted a great deal of attention in recent years.7 
The establishment of a community court might represent a 
novel approach to this old issue. 
(Johnny Connolly)
1.  Dublin City Business Association (2014, 29 January) Dublin 
City Business Association calls for a working committee to 
establish community courts for the capital. Press release issued 
by the DCBA at its seminar in Dublin. www.dcba.ie
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In October 2011 the HSE rolled out the national pharmacy 
needle exchange programme, which is a partnership 
initiative between the Elton John Aids Foundation, the 
Irish Pharmacy Union and the Health Service Executive 
(HSE). The programme targets counties outside of Dublin 
and will run to September 2014. Once pharmacies have 
signed a service level agreement with the HSE, their contact 
details are passed on to the relevant HSE services so that 
they can promote access to sterile injecting equipment 
at the participating pharmacies and accept referrals for 
investigation and treatment. 
There were 42 pharmacies providing needle exchange at 
the end of 2011 and this had increased to 71 by the end 
of 2012. There are pharmacies providing needle exchange 
in each regional drugs task force area (Table1) apart from 
those covering counties Dublin, Kildare and Wicklow, which 
are served by a mix of static and outreach needle-exchange 
programmes. The data used to prepare this article were 
collected from participating pharmacies by the HSE. 
 
 
Table 1 Number of pharmacy needle exchanges at the end of 2011 and 2012
Regional drugs task force area 2011 2012
Midland (Longford, Laois, Offaly, Westmeath) 1 414
Mid West (Clare, Limerick, North Tipperary)
20 2464
North Eastern (Meath, Louth, Cavan, Monaghan)
101 1377
North West (Sligo Leitrim, West Cavan, Donegal) 0 4
Southern (Cork and Kerry)
199 3124
South East (Carlow, Kilkenny, Waterford, Wexford. South Tipperary)
250 3424
Western (Galway, Mayo, Roscommon) 0 250
  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
 Unique Individuals 199 197 264 282 298 382 360 329 494 494 449 573
 Male 158 152 185 233 243 296 274 247 380 380 354 459
 Female 41 45 54 49 57 86 85 81 117 117 95 110
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Figure 1 Number of individuals attending needle exchange, by gender, 2012
Pharmacy needle exchange in Ireland
2.  Both presentations can be downloaded from the website of 
the DCBA at www.dcba.ie
3.  Lang J and Bowen P (2014, 29 January) Parliamentary 
Debates Dáil Éireann (Official report: unrevised). Joint 
Committee on Justice, Defence and Equality debate. 
Community courts system: discussion. http://
oireachtasdebates.oireachtas.ie/
4.  Henry K and Kralstein D (2011) Community courts: the 
research literature. A review of findings. Washington: US 
Bureau of Justice Assistance. www.courtinnovation.org/
research/community-court-research-literature
5. National Crime Council (2007) Problem solving justice: the 
case for community courts in Ireland. Dublin: Stationery Office. 
www.crimecouncil.gov.ie/index.html
6.  See article on Probation Service report in this issue. See 
also: Institute of Criminology (2003) Public order offences 
in Ireland: a report by the Institute of Criminology, Faculty of 
Law, University College Dublin for the National Crime Council. 
Dublin: Stationery Office. www.drugsandalcohol.ie/5437
7.  Strategic Response Group (2012) A better city for all: a 
partnership approach to address public substance misuse and 
perceived anti-social behaviour in Dublin city centre. Dublin: 
Strategic Response Group. www.drugsandalcohol.ie/17769
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  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
 No. of transactions 522 587 617 687 795 896 838 814 1249 1201 1186 1209
 10 packs given out 617 594 770 788 907 986 961 698 1419 1342 1069 1272
 10 pack returns 295 265 324 352 345 359 325 318 575 501 376 435
Figure 2 Numbers of transactions at needle exchange, packs distributed, and used packs returned, 2012
An average of 360 individuals attended pharmacy-based 
needle exchanges each month in 2012. The number of 
individual drug users using sterile injecting equipment 
increased by 188%, from 199 in January 2012 to 573 in 
December (Figure 1). Male attendees comprised 78% of 
individual attenders, and had an average age of 31 years;  
the average age of female attendees was 29 years. 
The needle exchanges completed 10,601 transactions in 
2012, distributing 11,693 packs; each pack contains 10 
sets of injecting equipment. The number of transactions 
increased by 132%, from 522 in January 2012 to 1,209 in 
December and the number of packs distributed followed 
a similar trend (Figure 2). Each individual user received 
an average of 2.7 packs (27 needles and syringes) in a 
calendar month in 2012. Thirty-eight per cent of the injecting 
equipment provided by pharmacies was returned for disposal. 
The pharmacy needle exchanges provides a link between 
harm reduction services and drug treatment services through 
referring individuals for bloodborne viral testing (253 in 
2012), hepatitis B vaccination (165) and to tier three and tier 
four services (261). 
(Jean Long, Joe Doyle and Denis O’Driscoll)
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HSE services in 2014 – illicit drugs, 
smoking and alcohol misuse
Approved by the Minister for Health on 17 December 
2013, the HSE’s National Service Plan 2014 sets out the type 
and volume of services the HSE will provide during 2014.1 
With the health services budget for the year reflecting cost 
reductions of €619 million, and against a backdrop of a 
reduction in overall health service funding of almost €4 
billion since 2008 and staff reductions of over 10,000 in  
that time, the HSE’s top priority in 2014 is to protect the 
volume, quality and safety of frontline services. 
Social Inclusion Services
‘Addiction issues’ are addressed by Social Inclusion Services 
in the Primary Care Division of the HSE. Social Inclusion 
Services support equity of access to services and provide 
targeted interventions to improve the health outcomes of 
minority groups, including Irish Travellers, Roma, and other 
members of diverse ethnic and cultural groups, such as 
asylum seekers, refugees and migrants, lesbian, gay, bisexual 
and transgender service users. Specific interventions are 
provided to address addiction issues, homelessness and 
medical complexities. 
The key priorities for 2014 that may be expected to have an 
impact on addiction issues are set out on p.37 of the plan: 
 ■ achieve improved health outcomes for persons with 
addiction issues;
 ■ deliver on the national policy objectives of the national 
drugs strategy 2009–2016,2 with specific reference to 
progressing implementation of relevant actions on early 
intervention, treatment and rehabilitation;
 ■ implement recommendations from Health Service Opioid 
Treatment Protocol;
 ■ implement recommendations with regard to Tier 4 in the 
residential addiction services report3 within the context of 
available resources;
 ■ evaluate the Pharmacy Needle Exchange Programme and 
make recommendations;
 ■ finalise the implementation plan for the National 
Overdose Prevention Strategy;
 ■ prioritise and implement Health Service actions in the 
report on a national substance misuse strategy;4
 ■ implement recommendations of the national hepatitis C 
strategy5 according to updated time frames and in line 
with existing resource constraints; and
 ■ implement the specific health aspects of a housing-
led approach to homelessness in line with the national 
homelessness policy statement.6
Key Performance Indicators for HSE Social Inclusion Services, 2014 
Expected Activity/ 
Target 2014
Opioid Substitute Treatment
No. of clients in opioid substitute treatment (outside prisons)
9,100
Substance Misuse
No. and % of substance misusers (over 18 years) for whom treatment has commenced within 
one calendar month following assessment.
1,260 (100%)
No. and % of substance misusers (under 18 years) for whom treatment has commenced within 
one week following assessment
105 (100%)
Pharmacy Needle Exchange
No. of unique individuals attending pharmacy needle exchange
700
Homeless Services
No. and % of individual service users admitted to homeless emergency accommodation hostels/
facilities whose health needs have been assessed as part of a Holistic Needs Assessment (HNA) 
within two weeks of admission
1,700 (85%)
Source: Health service national service plan 2014. p.38.
Health and Wellbeing Division
Smoking and alcohol misuse are addressed by the Health 
and Wellbeing Division of the HSE, which provides people 
with knowledge, services and supports to help them live 
healthier and more fulfilled lives. In 2014, in order to reduce 
the chronic disease burden, this division has identified the 
following ‘key priorities’:
 ■ support a package of programmes to reduce  
alcohol misuse; 
 ■ produce an implementation plan for recommendations 
identified in both the national substance misuse strategy 
report3 and the 2013 tobacco control strategy;7 and
 ■ integrate and develop a one-stop model for all smoking 
cessation services in the health service. 
Among the key performance indicators for the Health and 
Wellbeing Division are two tobacco-related indicators:
 ■ Number of frontline healthcare staff trained in brief-
intervention smoking cessation: 1,350
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 ■ Number of smokers receiving intensive cessation support 
from a cessation counsellor: 9,000
The Health and Wellbeing Division will also work to enforce 
the Public Health (Tobacco) Act and other tobacco control 
legislation, targeting areas of least compliance. 
(Brigid Pike)
1.  Health Service Executive (2013) Health service national  
service plan 2014. Dublin: Health Service Executive.  
www.drugsandalcohol.ie/21092/ 
2.  Department of Community, Rural and Gaeltacht Affairs 
(2009) National drugs strategy (interim) 2009–2016. Dublin: 
Department of Community, Rural and Gaeltacht Affairs. 
www.drugsandalcohol.ie/12388/ 
3.  Corrigan D and O'Gorman A (2007) Report of the HSE 
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Table 1 Recommended changes to the Dublin North City and County addiction service 
Service recommendations Operational recommendations
Deliver addiction services around clinical care pathways for 
drugs and alcohol, with a focus on recovery. 
All service users should have agreed care plans which should 
be reviewed and updated regularly
Organise addiction services to treat all addictions (including 
alcohol and stimulants) in multi-disciplinary teams which are 
locality based.
Locality teams should provide support to individuals with 
drug and alcohol problems who are treated by primary  
care services.
Develop specialist resources and services around dual 
diagnosis, pregnancy, hepatitis C, assisted withdrawal for 
individuals with complex needs, and children, young people 
and families.
All interventions should be evidence based and service 
providers should have appropriate training and supervision 
to ensure effective delivery.
Appoint a clinical director who should jointly chair the senior 
management team, and a designated clinical lead for each 
locality team and specialist services.
Assisted withdrawal (detoxification) services and 
rehabilitation services should be developed as a part of all 
care pathways.
Appoint a service manager who should jointly chair the 
senior management team; all staff should have clear lines  
of accountability.
Provide formal structures to enable service users to 
contribute to the design and evaluation of care.
Have in place a routine outcome monitoring programme; 
outcomes should link to agreed clinical and service 
performance measures
Appoint a designated implementation manager 
and establish a steering group to implement the 
recommendations in this report.
Develop a clinical governance structure to support the work 
of all clinicians in the addiction service.
Assessment of need and regular reviews of identified need 
should be central to the delivery of addiction services.
Source: Pilling and Hardy (2013), pp.6–7 .
Review of Dublin North City and County 
addiction service
A recent high-level review of addiction treatment services 
in the Dublin North City and County area concludes that a 
substantial reconfiguration of services is needed to effectively 
respond to population needs and emerging national policy.1 
The report contains 14 recommendations, eight to reconfigure 
services and six to reconfigure operational elements (Table 1). 
HSE>services>in>2014>(continued)
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The review team drew heavily on consultations with 
representatives from a range of staff groups, including 
psychiatrists, pharmacists, voluntary sector representatives, 
service users and outreach workers. In summarising the 
main issues to emerge from these consultations, the authors 
acknowledge that while many elements of the service  
work well: 
The current service configuration is sub-optimal, meaning 
that it is not always possible for staff to deliver care in line 
with an evidence-tiered approach…. The service currently 
consists of a number of professional/staff groups, some 
of whom appear to have limited formal interaction 
with one another…. There are also a number of ad-
hoc arrangements in place, with staff providing good 
services but again these are often not properly integrated 
within the wider service system…. Services have typically 
evolved, often without an overall strategic direction, 
responding to specific issues or opportunities. (p.20)
The authors identify a lack of integration between the 
different elements of service provision. They also point 
out that, in the main, the primary functions of addiction 
treatment services across the area are to assess opioid 
dependence and dispense methadone. They see the scope 
of service provision needing expansion to prioritise responses 
to alcohol misuse, co-morbid mental health disorders, non-
opiate drug misuse and the physical healthcare of service 
users. They also state that a detailed and comprehensive 
needs assessment is required to document the nature and 
level of services required by people across the area with 
addiction-related needs. 
Finally, the authors recommend that ‘in line with 
international opinion, the principle of recovery should 
underpin all treatment from the point of first contact’ 
(p.20). They draw on the following definition of recovery: 
‘an individual, ‘person-centred journey, enabling people to 
gain a sense of control over their own problems, the services 
they receive, and their lives and providing opportunities to 
participate in wider society’ (p.22). 
As the authors rightly point out, addiction recovery is 
becoming the guiding principle for substance use treatment in 
a number of jurisdictions. For example, US policy on substance 
use is increasingly promoting recovery and recovery support 
services,2 while, closer to home, current drug policies in 
England and Wales3 and in Scotland4 give a prominent role to 
recovery. The EU action plan on drugs5 call’s on member states 
to implement recovery and social reintegration services as part 
of a wider demand reduction pillar. 
This review is both insightful in reflecting on the past and 
current situation and illuminating in charting a reflective path 
to guide the future development of the Dublin North City 
and County addiction service. Grounded in the developing 
consensus of international research, the recommendations 
if implemented could transform the delivery of addiction 
services across the area and beyond. In the words of the 
review team,
Implementing the recommendations in this report will 
not only bring the service in line with national policy 
expectations, but will place it in a strong position to 
become the leader in addiction treatment in Ireland. 
(p.34) 
(Martin Keane)
1. Pilling S and Hardy R, with Psychological Interventions 
Research Centre (UCL) review team (2013) Review of the 
Dublin North City and County addiction service. Dublin: HSE 
Addiction Services. www.drugsandalcohol.ie/21143
2. Laudet AB and Humphreys K (2013) Promoting recovery in 
an evolving policy context: what do we know and what do 
we need to know about recovery support services? Journal of 
Substance Abuse Treatment, 45: 126–133.
3. UK Home Office (2010) Drug strategy 2010. Reducing 
demand, restricting supply, building recovery: supporting people 
to live a drug free life. London: Her Majesty’s Government.
4.  The Scottish Government (2008) The road to recovery: a new 
approach to tackling Scotland's drug problem. Edinburgh: The 
Scottish Government. 
5.  Council of the European Union (2013) EU action plan on 
drugs (2013–2016). Brussels: Council of the European Union.
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Substance misuse in the eastern 
counties of HSE South 
The Health Service Executive (HSE) South published the report 
Data co-ordination overview of drug misuse 2012 in November 
2012.1 This overview reports on treated substance misuse 
in the south-eastern counties of Carlow, Kilkenny, South 
Tipperary, Waterford and Wexford. The report comprises 
sections relating to treatment services and substance-related 
offences in the region. 
The section on treatment services analyses data collected from 
statutory and voluntary drug and alcohol treatment agencies, 
acute general hospitals and psychiatric hospitals in the region. 
Data from the drug and alcohol treatment services are returned 
to the National Drug Treatment Reporting System in the Health 
Research Board. 
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Table 1 Main problem drug and numbers treated in 2010 and 2011 
Main problem drug 2011 2012 +/- %
Alcohol 1830 1705 -125 7%
Heroin 461 529 +68 15%
Cannabis 498 522 +24 5%
Cocaine 81 65 -16 20%
Benzodiazepines 63 97 +34 54%
Other opiate-type drug 39 39 - -
Source: Data from Kidd (2013)
The total number of individuals seeking treatment in 2012 
was 3,719, a decrease of 17 on the 2011 figure. Some 236 
concerned persons (family members or close friends of 
substance users) contacted treatment services in the south east 
in 2012.
Excluding clients who were assessed only and those who 
were treated for addictions other than substance misuse, the 
combined total of continuous care clients and new referrals 
treated in 2012 was 3,012. Of these: 
 ■ 67% were male and 33% were female.
 ■ 6% were under the age of 18, and 23% were aged 
between 18 and 24. 
 ■ 56% were aged under 35.
 ■ Alcohol (57%) was the most common main problem 
substance for which treatment was sought, followed by 
heroin (18%), cannabis (17%), benzodiazepines (3%) 
and cocaine (2%). 
Since 2011 the numbers treated for alcohol as a main problem 
substance decreased by 7%, and for cocaine by 20%. There 
was a notable increase (54%) in the number treated for 
benzodiazepines as a main problem drug (Table 1). 
According to the report, the increase in the numbers 
presenting for treatment for heroin may be owing to a new 
methadone clinic in South Tipperary and the expansion of 
the Waterford treatment service. In addition, at the end of 
2012 there were 17 GPs in the region providing Level 1 
services for 61 clients addicted to opiates, and services were 
supported by 54 pharmacies. 
The first needle exchange service in the south east was 
developed in 2011 in Waterford. In 2012 there were an 
additional four such services operating from fixed sites 
– in Carlow, Kilkenny, Wexford and South Tipperary. Ten 
pharmacies in the region also provided needle exchange 
services in 2012. 
A total of 2,052 clients exited the services in 2012. More 
than one third (35%) of these clients completed treatment; 
26% refused further sessions or did not return for subsequent 
appointments; 18% withdrew as they considered themselves 
to be stable; 12% were transferred to another site for further 
treatment; 4% exited because of non-compliance; 4% exited 
for other reasons; and 0.5% had died.
The overview reports the most recent Garda data on drug 
offences published by the Central Statistics Office. The 
number of cases in the south east region in 2011 that gave 
rise to relevant proceedings were: 
 ■ Importation, cultivation or manufacture of drugs –  
63 cases
 ■ Possession for sale of supply, or for personal use –  
1,243 cases
 ■ Forged or altered prescriptions, or obstruction –  
32 cases
(Joan Moore)
1.  Kidd M (2013) Data co-ordination overview of drug misuse 
2012. Waterford: HSE South. www.drugsandalcohol.
ie/21262
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Fifteenth annual Service of 
Commemoration and Hope
On Saturday 1 February the National Family Support 
Network (NFSN) held its fifteenth annual Service of 
Commemoration and Hope, entitled ‘Supporting Our 
Family’, in remembrance of loved ones lost to substance 
misuse and related causes, and to publicly support families 
living with the devastation that substance misuse causes.
The service was preceded by a procession from the spire 
on O’Connell Street to Our Lady of Lourdes Church, 
Sean McDermott Street, led by the Garda band. Those in 
attendance included Counsellor Lucy McRoberts representing 
the Lord Mayor of Dublin, Bishop Eamonn Walsh, Fr Tim 
Wrenn and other religious representatives, as well as family 
members, friends, and many people working in this area. 
Music was provided by the soprano Nickola Hendy and 
Gardiner Street Gospel Choir.
In her address to the gathering, Sadie Grace of the NFSN 
spoke about the increase in poisoning deaths reported by 
the National Drug-Related Deaths Index, specifying the 
main drugs implicated in these deaths, namely; alcohol, 
benzodiazepine and antidepressants. She also mentioned 
the significant increase in deaths in which methadone was 
implicated and emphasised that behind these statistics 
are devastated families. Sadie spoke about the impact of 
substance misuse on children and extended family members, 
and about the sibling-support programme developed by the 
NFSN. She stressed the importance of providing services for 
children and support for grandparents taking on the role 
of caring for these children. The NFSN will continue to roll 
out its training programmes on responding to drug-related 
intimidation and the ‘5-step’ method in different parts of  
the country. 
Sadie acknowledged the growth of NFSN. evidenced by 
the presence of representatives from family support groups 
throughout the island of Ireland, and how vital it is that 
families are represented on decision-making bodies as they 
are directly affected by substance misuse. She urged that 
support of family members living with substance misuse 
be prioritised.
In his reflection, Fr Edmond Grace reflected on the pain 
families have gone through and the need for healing and 
hope. Brigid Sugrue, a member of the NFSN Bereavement 
Support Group, gave a moving testimony about her journey 
through living with the devastation of her daughter’s drug 
addiction and subsequent death due to drug misuse. She 
sincerely acknowledged the tremendous work of the NFSN 
Bereavement Support Group and the vital support she has 
received from this group.
Anna Quigley of CityWide recited poetry by Emily Dickinson. 
Bill O’Dea of the Child and Family Agency read a message for 
the service on behalf of Pope Francis. Godfrey Chimbganda 
of the New Communities Partnership said a prayer. Kenny 
Hartnett, a member of UISCE (service users’ representative 
forum), gave a very honest and emotional speech about 
his experience as a drug user. In his address Archbishop 
Diarmuid Martin spoke of how moving he found the service. 
He spoke of the broken lives, the isolation, fear, and path 
of destruction caused by substance misuse; however, he 
stressed that the path of hope must never be abandoned.
You can contact the National Family Support Network at 16 
Talbot Street,,Dublin 1. Tel: 01 836 5168; email: info@fsn.ie; 
web: www.fsn.ie
(Ena Lynn)
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City Clinic marks 20 years in  
addiction services
The City Clinic is a HSE-funded drug treatment centre in 
Amiens Street in north Dublin. Set up in April 1993 as a 
public health and harm reduction response to the inner city's 
growing heroin problem, the clinic celebrated 20 years of 
service in December 2013 with the launch of The City Clinic: 
20 years of reflections, remembrances and recollections 1993 
–2013.1 The booklet, with contributions from current and 
former staff, clients and others associated with the clinic, 
traces the work and development of the clinic since its 
inception. 
Contributors to the booklet share personal memories of the 
City Clinic over the past 20 years, including those who recall 
its early days, their memories of the drug situation at the 
time and of the events and people that led to the setting up 
of the clinic. 
Dr Des Crowley states that the pattern of drug use and 
the service-user profile of clients of the City Clinic have 
changed over the past 20 years. Now, clients often have 
polysubstance drug and alcohol abuse problems, clients in 
treatment have an increasing age profile and their health and 
treatment needs are changing. There are significant levels of 
dual diagnosis among the clinic’s patient group. 
Dr Crowley also states that drug treatment services have 
changed radically over the last 20 years and that the success 
of the City Clinic is substantial. Clients have immediate 
access to treatment and a retention rate for those in 
treatment of 98%. He goes on to say: 
The success in almost eliminating the spread of HIV 
infection among drug injecting community is a testament 
to the success of a harm reduction and public health 
approach to drug addiction … . The development of care 
planning and risk assessment has significantly improved 
patient outcomes across a range of measures. (p.7).
The City Clinic now has a staff of 25 multi-disciplinary health 
professionals, including admin staff, doctors, pharmacist, 
counsellors, nurses, outreach, general assistants, a rehab and 
integration worker and a midwife, to address the complex 
medical and psycho-social needs of clients. The clinic has 
treated over 1,300 patients since 1993 and adopts an inter-
agency approach within the community to maximise all 
available treatment resources, so as to meet the care needs 
of clients. 
(Ita Condron)
1.  The City Clinic (2013) The City Clinic: 20 years of reflections, 
remembrances and recollections 1993 –2013. Dublin: The City 
Clinic. www.drugsandalcohol.ie/21037
Ava Stapleton, counsellor; Des Crowley, GP co-ordinator; and 
Jo-Anne Sexton, counsellor/ psychotherapist, at the launch
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Ruhama annual report 2012
Ruhama is a non-governmental organisation that works on 
a nationwide basis with women affected by prostitution. 
Ruhama provides support and assistance to women who 
are active in prostitution, have a history of prostitution, or 
are victims of sex trafficking. The latest annual report shows 
that the service worked with 258 women, of 32 different 
nationalities.1 This article briefly describes some the main 
programmes of work reported by Ruhama for 2012. 
Street outreach service
The Ruhama street service of 30 outreach workers, including 
staff and volunteers, worked 108 nights during 2012 and 
supported 72 women, some on multiple occasions; 10 of 
the women also engaged with Ruhama’s casework service. 
The outreach service uses a purposely adapted vehicle 
which is referred to as ‘the van’ by service users throughout 
the report. The report documents the issues that women 
involved in street prostitution present with, including 
addiction, debt, homelessness, poor health, suicidal ideation 
and violence. Ruhama is particularly conscious of the 
negative role that addiction plays in the lives of women 
engaged in prostitution.  
 
According to the report: 
A majority of women involved in street prostitution who 
accessed Ruhama services via the Outreach Van in 2012 
led chaotic lives due to their drug misuse. Ruhama has 
noted that this particular cohort of women may not 
access the full services offered, particularly those available 
in education and development. Ruhama has proactively 
engaged with low threshold drugs services to ascertain 
what kind of interaction with education best suits the 
client needs, and with this in mind is developing a 
number of once-off workshops that women could access 
without having to sign up for regular classes. (p.15)
Casework
In 2012, there were 170 women in casework; 45 were 
new cases in general casework and 18 were new cases 
in victims of trafficking casework. The other 107 women 
were in casework from before the start of 2012. Casework 
involves the woman working individually with a caseworker 
to identify goals and address pertinent issues and needs 
in a planned way; the woman may also receive emotional 
support through counselling. Women who are deeply 
traumatised are also offered psychotherapy and some may 
benefit from art therapy. It usually takes approximately two 
years for a woman affected by prostitution to work through 
a care plan. 
Education and development
Providing education and development services is referred 
to as a cornerstone of Ruhama’s work. In 2012, 88 women 
engaged with Ruhama‘s education and development 
programme, an increase of 14% on the 2011 figure. Table 
1 provides a detailed breakdown of the numbers of women 
and the activities they engaged with. 
Additional services
Ruhama employs a specific worker to assist women to access 
suitable housing and accommodation; this service also assists 
women to access social welfare benefits and entitlements. In 
2012, 33 women availed of Ruhama‘s resettlement support 
service. Assisting and supporting women to exit prostitution 
and to deal with the emotional and material experience of 
prostitution are key objectives of the organisation, as is its 
mission to support women to (re)gain their independence 
and eventually exit the services provided by Ruhama. The 
annual report shows that, in the course of 2012 Ruhama had 
been able to close the case files on 49 clients, meaning that 
the women had worked through their care plans and were 
no longer reliant on the services. 
Table 1 Development and education activities engaged in and number of participants
Activity Participants Activity Participants
Developed a career path plan 47 Engaged in group classes 33
Had one-to-one study skills 10 Worked on developing CVs 50
Did IT training 9 Learned English as second language 22
Started FETAC courses 11
Applied for third-level/further education  
or training
52
Completed FETAC courses 7 Received financial support to assess education 45
Source: Ruhama (2013), p.14.
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Conclusion
The annual report compiled by Ruhama and briefly 
described in this article is a useful insight into the nature and 
extent of work undertaken by the organisation with women 
affected by prostitution and human trafficking. However, 
work of this kind with such vulnerable and marginalised 
people can rarely be captured by reference to numbers and 
categories.  
 
Inchicore Bluebell team launches 
strategy document
On 5 December 2013 Alex White TD, Minister of State with 
responsibility for the National Drugs Strategy, launched 
the Strategic Plan 2014–2017 of the Inchicore Bluebell 
Community Addiction Team (IBCAT).1 Celine Martin, 
project director of the strategic review team, introduced 
the event, which was followed by a screening of the ‘Taking 
Stock’ media arts project by Joe Lee. This moving piece of 
work gave a snapshot of the lives of service users in their 
own words. The event was also addressed by Conor Daly, 
chairperson of the review team.
The plan outlines the research carried out by IBCAT 
among all stakeholders in the service – service users, local 
community groups, residents, staff and health professionals. 
The main findings of the research are outlined below.
 ■ Polydrug use is the norm for service users, with most 
clients using two or more substances.
 ■ Alcohol and herbal cannabis are presenting as  
growing problems.
 ■ Heroin, benzodiazepine and methadone use is clearly 
evident among service users.
 ■ Family members, especially children, significantly benefit 
from the services provided through a community model 
of addiction treatment.  
 ■ Wider effects of addiction on the local communities are 
providing new challenges that need intervention. 
The rates of drug and alcohol use identified highlight the 
huge challenges facing policy makers and care providers. It 
is hoped that the information contained within this plan will 
provide a unique insight into current and emerging needs.
For further information or to download a copy of the plan, 
please go to www.icdt.eu 
(Vivion McGuire)
1. Inchicore Bluebell Community Addiction Team (2013) 
Strategic Planning document 2014–2017. Dublin: ICDT.  
www.drugsandalcohol.ie/21049
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Minister Alex White TD (Photo by Karen Stein Photography)
In the words of the chairperson of Ruhama: 
In this report we read many statistics, and behind each 
one is an individual woman’s story, a personal experience, 
where she has been trafficked, coerced or otherwise 
socialised into a life which she now wishes to leave, but 
where her escape may be threatened by danger, fear and 
absence of options. (p.3) 
(Martin Keane) 
 
1.  Ruhama (2013) Ruhama annual report 2012. Dublin: 
Ruhama. www.drugsandalcohol.ie/20863
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National Documentation Centre: new 
and updated resources
Online tutorials
To help you get the most value from our website we 
have created two short tutorials on using the National 
Documentation Centre on Drug Use (NDC), Ireland’s drugs 
library. Each video is about five or six minutes long and is 
divided into separate sections for easy navigation. A text 
version of each is also available. On the NDC home page 
(www.drugsandalcohol.ie) click on TUTORIALS on the orange 
toolbar to get to the videos:
1. Overview and introduction to NDC website
2. Searching the collection 
 
Factsheets
The key resources section on the home page of the NDC 
website includes Factsheets on cannabis, cocaine, opiates, and 
sedatives. The Factsheets contain the most recent published 
data on these drugs and can be accessed via the links below.
Factsheet: Cannabis – the Irish situation (December 2013)  
www.drugsandalcohol.ie/17307
Factsheet: Cocaine – the Irish situation (January 2014)  
www.drugsandalcohol.ie/17308
Factsheet: Opiates – the Irish situation (January 2014)  
www.drugsandalcohol.ie/17313
Factsheet: Sedatives and tranquillisers – the Irish situation  
(January 2014) www.drugsandalcohol.ie/19644
From Drugnet Europe
Kick-off: Joint action on reducing alcohol-related harm 
Cited from article by Maria Moreira in Drugnet Europe No. 
85, January–March 2014
Harmful and hazardous alcohol use is one of the main causes 
of premature death and avoidable disease in the EU today. 
Highlighting the importance of this issue, the European 
Commission (EC) is funding the Joint action on reducing 
alcohol-related harm (RARHA) project, which was launched in 
Lisbon on 31 January. … [T]he initiative involves 32 associated 
partners and 28 collaborating partners from both EU and non-
EU countries. The EMCDDA is among the project’s associated 
partners and also sits on its Advisory Group. 
…The project aims to mobilise countries to develop common 
approaches in line with the EU alcohol strategy, including: 
developing methodologies to conduct alcohol surveys and 
pool data for comparative assessments; translating scientific 
evidence and knowledge into practical implications for good 
practice in alcohol-related interventions; and producing a 
toolkit of potentially transferable interventions with evidence 
of effectiveness and cost estimates. 
For many years, there has been considerable policy concern 
about the interaction between alcohol and drug use in 
Europe. The EMCDDA’s own remit was broadened in 2006 
to include the monitoring of polydrug use, where illicit drugs 
are taken in combination with licit substances or medication. 
For more, see www.emcdda.europa.eu/news/2014/sicad-
rarha-conference
Focus on multidimensional family therapy 
Cited from Drugnet Europe No. 85, January–March 2014
The family can play a vital role in addressing the issue of 
substance use disorders among adolescents. This is according 
to the latest edition in the ‘EMCDDA Papers’ series — 
Multidimensional family therapy for adolescent drug users:  
a systematic review — released on 6 February. 
Adolescence is a period in human development during 
which individuals are more prone to risk-taking and less 
prone to impulse control. Some young people experiment 
with both licit and illicit substances during this time and this 
can have an impact on their behaviour, their relationships 
with others and their functioning in society. The new report 
explores multidimensional family therapy (MDFT), a form of 
inclusive therapy involving the young person, their family 
and their environment. Based on five studies carried out 
in the United States and the EU, the paper shows how this 
holistic approach can deliver promising results that are visible 
both during, and after, therapy. For more, see www.emcdda.
europa.eu/publications/emcdda-papers
Exploring methamphetamine trends in Europe 
Cited from Drugnet Europe No. 85, January–March 2014
Concerns about the availability and use of 
methamphetamine in Europe have been growing for 
some time. Historically, use of the drug has been confined 
largely to the Czech Republic and Slovakia. However, 
reports of increasing methamphetamine use from different 
European countries in 2012 and 2013 sparked an interest in 
investigating this topic further. The EMCDDA has responded 
with Exploring methamphetamine trends in Europe which aims 
to increase the overall understanding on this drug in Europe. 
The ‘EMCDDA Paper’, released on 31 January, follows 
trendspotter meetings held at the agency in September 
2013. The report focuses on production and trafficking 
issues, prevalence and patterns of use, health and social 
harms, and responses to the problem. For more, see  
www.emcdda.europa.eu/publications/emcdda-papers 
Drugnet Europe is the quarterly newsletter of the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA).  
It is available at www.emcdda.europa.eu
If you would like a hard copy of the current or future issues,  
please contact:
Health Research Board 
Knockmaun House 
42–47 Lower Mount Street 
Dublin 2
Tel: 01 234 5148 
Email: drugnet@hrb.ie
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Recent publications
Journal articles
The following abstracts are cited from recently published 
journal articles relating to the drugs situation in Ireland.
Library value and impact: taking the step from knowing it 
to showing it 
Dunne M, Nelson M, Dillon L and Galvin B  
Library and Information Research, 2013, 37(116). 
www.drugsandalcohol.ie/21577
The National Documentation Centre on Drug Use (NDC) is 
a unique Irish information resource that embraces elements 
of several library types: national, public, special, academic, 
digital, and health. This paper presents the results of an 
evaluation study carried out by NDC staff in two parts, a 
value survey and impact interviews. Both quantitative and 
qualitative methods were used to examine aspects of the 
value and impact of the NDC’s resources and services. Many 
elements of our approach worked well and contributed to 
the achievement of our aims and objectives. We outline our 
approach and suggest some modifications that we might 
make if we were to repeat the study.
Based on the views and experiences of respondents, we can 
say that the NDC’s services and resources are valued by our 
users and have had positive impacts on their work. These 
impacts have been wide-ranging and have brought about 
affective, knowledge-based, behavioural, and competence-
based change in practice. The study provides the NDC with 
a significant body of evidence on which to base plans for the 
development of resources and services over the next  
few years.
‘Lead us not into temptation’: adolescence and alcohol 
policy in Europe 
Hope A  
Alcohol and Alcoholism, 2014, 49(2): 126–127. 
www.drugsandalcohol.ie/21446
Although the World Health Organization and the European 
Community recognize harm to children and young people 
due to alcohol – whether their own or someone else’s 
drinking, effective policies to reduce harm are not widely 
followed. The alcohol beverage industry’s drive to use 
social networking systems blurs the line between user-
generated and industry marketing materials, such that 
young people are more frequently and at a younger age, 
potentially exposed to the promotion of alcoholic drinks. This 
contravenes recommendations arising out of the emerging 
scientific literature that delaying the onset of drinking and 
reducing the prevalence of heavy session drinking are likely 
to promote a healthier next generation.
Alcohol and youth mental health – the evidence base
Fitzgerald A and Dooley B 
Psychiatry Professional, 2013, 2(1): 6–8.  
www.drugsandalcohol.ie/21265
The My World Survey–Second Level (MWS–SL) assessed 
alcohol-related behaviours in 6,085 adolescents. Findings 
demonstrated a significant shift in the frequency, binge 
drinking and volume of alcohol consumed across the 
school year. Alcohol use in the Senior Cycle was a particular 
concern, with 35% outside the low risk category for alcohol 
behaviour. The MWS-SL found a strong relationship between 
alcohol use and mental health distress. Risky alcohol 
behaviour was associated with family conflict and other 
negative behaviours.
Adolescent males in secondary school in Ireland: alcohol 
use and depressed mood
Kerr RA 
Irish Journal of Applied Social Studies, 2013, 13(1): Article 3.  
www.drugsandalcohol.ie/21266
Per capita alcohol consumption by Irish teenagers has 
doubled over the past three decades. There has also been 
a doubling of the suicide rate among young men. This 
study aimed to measure the correlation between alcohol 
consumption and negative mood (using the Beck Depression 
Inventory) in a sample (n = 169) of final-year secondary 
school male students. A questionnaire was devised to 
ascertain frequency, type and quantity of alcohol consumed, 
attitudes towards drinking in general, and to assess overall 
mood disturbance. These two sets of results were analysed 
and correlation coefficients calculated. It was found that both 
alcohol consumption and mood disturbance varied widely 
throughout the sample and that total alcohol consumption 
correlated weakly but significantly with overall mood 
disturbance. However, there was a stronger, more significant 
correlation between frequency of feeling drunk and mood 
disturbance, indicating a much greater effect on the 
teenagers’ mood from binge drinking than from consistently 
drinking the same quantity of alcohol.
A review of drug-facilitated sexual assault evidence: an 
Irish perspective 
McBrierty D, Wilkinson A and Tormey WP 
Journal of Forensic and Legal Medicine, 2013, 20(4): 189–197. 
www.drugsandalcohol.ie/21237
Drug-facilitated sexual assault (DFSA) is prevalent in Western 
society. There is a significant degree of confusion regarding 
the definition and prevalence of DFSA. It is a subject with 
medical, scientific and legal aspects. These facets are 
explored in this review through a detailed examination of 
published data. The legal issues are defined in the context 
of the Irish judicial system. Several key case-law studies are 
presented to aid in understanding unresolved difficulties 
that persist in this complex field of forensics. The aim of 
this paper is to aid individuals from disparate disciplines to 
increase their evidence base in the complex and evolving 
issue of DFSA.
Non-medical use of psychotropic prescription drugs 
among adolescents in substance use treatment 
Apantaku-Olajide T and Smyth BP  
Journal of Psychoactive Drugs, 2013, 45(4): 340–346.  
www.drugsandalcohol.ie/21192
Little is known about the extent of non-medical use of 
prescription drugs among European adolescents with 
substance use disorders. This cross-sectional study examined 
non-medical use of seven categories of psychotropic 
prescription drugs (opioid analgesics, ADHD stimulant, 
sleeping, sedative/anxiolytic, antipsychotic, antidepressant, 
and anabolic steroid medications) in a clinical sample of 
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Irish adolescents with substance use disorders. Of the 85 
adolescents (aged 13-18 years) invited to participate, 65 
adolescents (M = 16.3 years, SD = 1.3) took part (response: 
74%). Among respondents, 68% reported lifetime non-
medical use of any of the prescription drugs; sedative/
anxiolytic (62%) and sleeping medications (43%) were more 
commonly abused. The most frequently reported motives 
for abuse were “seeking high or buzz” (79%), “having good 
time” (63%), and “relief from boredom” (56%). Sharing 
among friends and street-level drug markets were the most 
readily available sources. Innovative solutions of control 
measures and intervention are required to address the abuse 
of prescription drugs.
Impact of new UK paracetamol overdose guidelines on 
patients presenting to the emergency department 
Nfila G, Lee S and Binchy J  
Irish Medical Journal, 2014, 107(2): 47. 
www.drugsandalcohol.ie/21455
Paracetamol is involved in a large proportion of overdoses 
that present to the Emergency Department (ED), either as 
lone or mixed overdoses. Non-treatment of toxic levels can 
lead to fulminant liver failure. This study is to determine the 
impact the new UK treatment guidelines1 will have on patients 
presenting with paracetamol overdose. A retrospective review 
was performed on all patients who had paracetamol levels 
done in the ED between September 2011 and August 2012. 
A total of 523 patients were identified, 95(18%) of whom 
had detectable paracetamol levels. 74 patients from the 
95 were evaluated. 18(24%) patients were treated with 
N-acetylcysteine as per the then paracetamol overdose 
guidelines. Using the new guidelines would have resulted in 
3 more patients being admitted. Our study shows that most 
patients who present following paracetamol overdose do not 
require treatment with N-acetylcysteine and suggests that 
the introduction of the new UK treatment guidelines is likely 
to result in only a small increase in the number of patients 
requiring treatment. 
Health-related quality of life of HIV-infected intravenous 
drug users 
Surah S, Adams R, Townsend L, Reynolds I et al.  
International Journal of STD & AIDS, 2013, 24(11): 867–874.  
www.drugsandalcohol.ie/21444
To investigate health-related quality of life in HIV-infected 
intravenous drug users registered but not engaged in 
HIV outpatient care we conducted a cross-sectional study 
to examine health-related quality of life of HIV-infected 
intravenous drug users registered for care at an inner city 
HIV unit. EQ-5D, SF-36, SF-6D, mood disorder, clinical and 
substance misuse data were collected. Mean scores and 
preference derived utility scores were calculated. 
Statistical relationships between health-related quality of 
life and other variables were explored using univariate and 
multivariate analysis. Fifty-five patients were recruited, 64% 
were males. The mean anxiety value was 11.44 (anxious) and 
mean depression score was 9.3 (borderline depressed). The 
mean EQ-5D utility was 0.45 (95% CI 0.35, 0.55) and mean 
SF-6D utility was 0.52 (95% CI 0.48, 0.55). There was no 
statistical relationship between HIV indices, substance misuse 
and EQ-5D and SF-6D utility. Anxiety and depression were 
significantly correlated with EQ-5D and SF-6D utility values 
on univariate and multivariate analysis. Health-related quality 
of life was reduced in this HIV-infected intravenous drug user 
population. Whilst hepatitis C co-infection and substance 
misuse did not affect health-related quality of life, anxiety and 
depression had a significant impact on it. 
Emergence of opiate-induced neonatal  
abstinence syndrome 
Healy D, English F, Daniels A and Ryan CA  
Irish Medical Journal, 2014, 107(2): 46. 
www.drugsandalcohol.ie/21454
Neonatal abstinence syndrome (NAS) is the clinical picture 
of infants withdrawing from in-utero substance exposure. 
The incidence of NAS rose in Dublin maternity hospitals in 
the 1970s and 1980s in parallel with increasing opiate abuse 
in that city. The purpose of this study was to determine if a 
similar pattern was emerging in Cork University Maternity 
Hospital. Data from the Erinville Hospital (2000-2007) and 
CUMH (2008-2011) were compared. Sixteen cases of NAS 
were identified, two at Erinville Hosptial and 14 at CUMH. 
Five of the 16 mothers were using heroin, while ten were 
on methadone maintenance. All were multi-drug abusers. 
Newborns requiring pharmacotherapy for NAS (5/16) had 
prolonged hospitalisations compared to those requiring 
supportive care. NAS in Cork is increasing. Primary, secondary 
and tertiary preventative measures are warranted to prevent 
further escalation.
Open drug scenes and drug-related public nuisance: a 
visual rapid assessment research study in Dublin, Ireland 
Van Hout MC and Bingham T  
Journal of Ethnicity in Substance Abuse, 2013, 12(2): 154-178. 
www.drugsandalcohol.ie/21345
The research was undertaken at a time of increasing public 
concerns for drug- and alcohol-related public nuisance in 
the city centre of Dublin, Ireland. Rapid Assessment Research 
was conducted involving qualitative interviewing with drug 
service users; business, transport, community, voluntary, 
and statutory stakeholders (n = 61); and an environmental 
mapping exercise.
The interplay between homelessness, loitering, an influx of 
drug users via city metro systems, transient open drug scenes, 
street drinking, drug injecting, intimidation, knife crime, 
and prescribed medication abuse was evident. Potential 
strategies to address drug and alcohol related public nuisance 
are advised to include the relocation of treatment services, 
targeted harm reduction initiatives, urban regeneration, 
improved community rehabilitation pathways, and 
heightened policing intensity.
Towards a Framework for implementing evidence based 
alcohol interventions 
Armstrong R and Barry J  
Irish Medical Journal, 2014, 107(2).  
www.drugsandalcohol.ie/21433
This study tested the feasibility of screening and brief interven-
tion (SBI) within four emergency departments. A total of 944 
patients were screened for hazardous and harmful alcohol use. 
The results showed that there was good co-operation from 
the public, with 888 (94%) people agreeing to be screened. 
The screening tool detected that 460 (49%) of those needed 
no intervention, 345 (36%) needed brief advice and 83 (9%) 
required referral to specialist services. This showed the value 
of the screening but also helped to reassure staff that people 
were happy to take part.
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Upcoming events
(Compiled by Joan Moore – jmoore@hrb.ie)
April
29–30 April 2014
Recovery from Addiction: Bridging the Gap between 
Policy and Practice 
Venue: University of Chester, UK 
Organised by/Contact: CSARS Group 
Email: roberts.t@chester.ac.uk 
Web: http://shopfront.chester.ac.uk/index.php?main_
page=product_info&products_id=298
Information: Recovery has become more central to the 
addictions treatment policy agenda than ever before, but 
the nature of recovery and means of achieving it are subject 
to vigorous debate. This event will provide a forum for 
policy makers, commissioners and practitioners, together 
with representatives from mutual aid groups and the wider 
recovery movement. It aims to raise awareness of the 
diversity of the recovery landscape and to build consensus 
towards more cohesive policy implementation. It will be 
useful to substance-misuse workers, health and social 
care professionals, probation & criminal justice workers, 
counsellors, psychotherapists and psychiatrists, members 
of mutual-aid groups and others involved with, affected by, 
or in recovery. Dr David Best, Associate Professor, Monash 
University, & Turning Point Alcohol and Drug Centre, 
Australia, will be among the keynote speakers. 
May
7–9 May 2014
2nd European Harm Reduction Conference 
Venue: Basel, Switzerland 
Organised by/Contact: European Harm Reduction Network 
(EuroHRN) 
Email: harmreduction@infodrog.ch 
Web: www.harmreduction.ch/en/
Information: The conference aims to offer an ideal platform 
to discuss the present and future of harm reduction and to 
promote the further development of the concept in different 
European countries. The most recent developments in harm 
reduction practice will be explored at the meeting as well as 
international models of regulating drugs. Registration for the 
conference is now open. 
15–16 May 2014
3rd international conference on novel  
psychoactive substances
NPS and behavioural addiction
Venue: Rome 
Organised by/Contact: EMCDDA and others  
Web: www.novelpsychoactivesubstances.org
Information: The event will be organised by: the University 
of Hertfordshire; the EMCDDA; the University of Chieti-
Pescara; ‘Sapienza’ University of Rome; and ‘Guglielmo 
Marconi’ University. The event is sponsored by the Società 
italiana di psichiatria. 
In the past 25 years a variety of novel (or ‘new) psychoactive 
drugs (NPS) have become available, and they are often 
misrepresented as ‘safer’ and ‘legal” alternatives to illicit 
drugs. NPS are often sold via the Internet, where information 
on their effects is minimal or inaccurate. This conference will 
offer participants an opportunity to share evidence-based 
information on NPS and improve understanding of prevention, 
treatment and management approaches in this area. 
21–23 May 2014
International Society for the Study of Drug Policy 
Eighth Annual Conference 
Venue: Rome 
Organised by/Contact: ISSDP 
Email: cibb@uniroma2.it 
Web: www.cibb.uniroma2.it/index.php/ct-menu-item-
28?id=71
Information: The 2014 ISSDP conference will be held 
in Rome, Italy, where state-of-the-art monitoring and 
epidemiology, along with innovative treatment, law 
enforcement and prevention approaches are all on display. 
The conference will provide a rich programme of world-class 
drug policy research from across the globe. 
22–23 May 2014
European Working Group on Drugs Oriented Research 
(EWODOR)
15th Symposium: Gender and Diversity
Venue: Trinity College Dublin 
Organised by/Contact: EWODOR/Coolmine Therapeutic 
Community 
Email: eoinc@coolminetc.ie 
Web: www.coolmine.ie/ewodor
Information:  EWODOR is a network of addiction researchers 
closely aligned to the European Federation of Therapeutic 
Communities (EFTC).  At this symposium you will learn, be 
inspired by discussion and debates, and be motivated in your 
day-to-day work through new research, skills and networking 
with colleagues.
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